US20180318464A1 - Intraocular lens material - Google Patents
Intraocular lens material Download PDFInfo
- Publication number
- US20180318464A1 US20180318464A1 US15/772,273 US201715772273A US2018318464A1 US 20180318464 A1 US20180318464 A1 US 20180318464A1 US 201715772273 A US201715772273 A US 201715772273A US 2018318464 A1 US2018318464 A1 US 2018318464A1
- Authority
- US
- United States
- Prior art keywords
- mass
- parts
- structural unit
- experimental
- intraocular lens
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000463 material Substances 0.000 title claims abstract description 150
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims abstract description 54
- 239000000178 monomer Substances 0.000 claims abstract description 47
- -1 alkoxyalkyl methacrylate Chemical compound 0.000 claims abstract description 34
- 125000003118 aryl group Chemical group 0.000 claims abstract description 22
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 20
- 238000004132 cross linking Methods 0.000 claims abstract description 7
- 125000005250 alkyl acrylate group Chemical group 0.000 claims description 18
- SFPNZPQIIAJXGL-UHFFFAOYSA-N 2-ethoxyethyl 2-methylprop-2-enoate Chemical group CCOCCOC(=O)C(C)=C SFPNZPQIIAJXGL-UHFFFAOYSA-N 0.000 claims description 15
- RZVINYQDSSQUKO-UHFFFAOYSA-N 2-phenoxyethyl prop-2-enoate Chemical group C=CC(=O)OCCOC1=CC=CC=C1 RZVINYQDSSQUKO-UHFFFAOYSA-N 0.000 claims description 15
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical group CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 claims description 13
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 claims description 13
- 125000000217 alkyl group Chemical group 0.000 claims description 12
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims description 11
- WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical group CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 claims description 9
- JHWGFJBTMHEZME-UHFFFAOYSA-N 4-prop-2-enoyloxybutyl prop-2-enoate Chemical group C=CC(=O)OCCCCOC(=O)C=C JHWGFJBTMHEZME-UHFFFAOYSA-N 0.000 claims description 2
- 229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 claims 1
- 125000003545 alkoxy group Chemical group 0.000 abstract description 4
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 37
- 229960005323 phenoxyethanol Drugs 0.000 description 37
- 238000004090 dissolution Methods 0.000 description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 29
- 239000000243 solution Substances 0.000 description 25
- 238000000605 extraction Methods 0.000 description 24
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 18
- 238000005259 measurement Methods 0.000 description 16
- 230000007062 hydrolysis Effects 0.000 description 15
- 238000006460 hydrolysis reaction Methods 0.000 description 15
- 238000010521 absorption reaction Methods 0.000 description 14
- 239000000203 mixture Substances 0.000 description 11
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 8
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 8
- 239000000413 hydrolysate Substances 0.000 description 8
- 229920000642 polymer Polymers 0.000 description 7
- 238000006116 polymerization reaction Methods 0.000 description 7
- 102100026735 Coagulation factor VIII Human genes 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- SOGAXMICEFXMKE-UHFFFAOYSA-N alpha-Methyl-n-butyl acrylate Natural products CCCCOC(=O)C(C)=C SOGAXMICEFXMKE-UHFFFAOYSA-N 0.000 description 6
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 5
- YOIZTLBZAMFVPK-UHFFFAOYSA-N 2-(3-ethoxy-4-hydroxyphenyl)-2-hydroxyacetic acid Chemical compound CCOC1=CC(C(O)C(O)=O)=CC=C1O YOIZTLBZAMFVPK-UHFFFAOYSA-N 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- 239000003086 colorant Substances 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 125000000524 functional group Chemical group 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 229920002554 vinyl polymer Polymers 0.000 description 4
- 239000003999 initiator Substances 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- 238000002203 pretreatment Methods 0.000 description 3
- 230000005855 radiation Effects 0.000 description 3
- 239000007870 radical polymerization initiator Substances 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 239000012086 standard solution Substances 0.000 description 3
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 3
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 description 2
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 2
- YXYJVFYWCLAXHO-UHFFFAOYSA-N 2-methoxyethyl 2-methylprop-2-enoate Chemical compound COCCOC(=O)C(C)=C YXYJVFYWCLAXHO-UHFFFAOYSA-N 0.000 description 2
- HPSGLFKWHYAKSF-UHFFFAOYSA-N 2-phenylethyl prop-2-enoate Chemical compound C=CC(=O)OCCC1=CC=CC=C1 HPSGLFKWHYAKSF-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 150000003926 acrylamides Chemical class 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 125000002947 alkylene group Chemical group 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- ISAOCJYIOMOJEB-UHFFFAOYSA-N benzoin Chemical compound C=1C=CC=CC=1C(O)C(=O)C1=CC=CC=C1 ISAOCJYIOMOJEB-UHFFFAOYSA-N 0.000 description 2
- 239000012965 benzophenone Substances 0.000 description 2
- GCTPMLUUWLLESL-UHFFFAOYSA-N benzyl prop-2-enoate Chemical compound C=CC(=O)OCC1=CC=CC=C1 GCTPMLUUWLLESL-UHFFFAOYSA-N 0.000 description 2
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 2
- CQEYYJKEWSMYFG-UHFFFAOYSA-N butyl acrylate Chemical compound CCCCOC(=O)C=C CQEYYJKEWSMYFG-UHFFFAOYSA-N 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- 239000003505 polymerization initiator Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 2
- BKKVYNMMVYEBGR-UHFFFAOYSA-N (2,3,4,5,6-pentabromophenyl) prop-2-enoate Chemical compound BrC1=C(Br)C(Br)=C(OC(=O)C=C)C(Br)=C1Br BKKVYNMMVYEBGR-UHFFFAOYSA-N 0.000 description 1
- DSTUKHPLWATFCG-UHFFFAOYSA-N (2-benzoylphenyl) prop-2-enoate Chemical compound C=CC(=O)OC1=CC=CC=C1C(=O)C1=CC=CC=C1 DSTUKHPLWATFCG-UHFFFAOYSA-N 0.000 description 1
- HWZBLCBBRFYCKB-UHFFFAOYSA-N *.B.C.CCOCCOC(=O)C(C)(CC(C)C(=O)OCCOC1=CC=CC=C1)CC(CC)C(=O)OCC Chemical compound *.B.C.CCOCCOC(=O)C(C)(CC(C)C(=O)OCCOC1=CC=CC=C1)CC(CC)C(=O)OCC HWZBLCBBRFYCKB-UHFFFAOYSA-N 0.000 description 1
- 0 *.B.C.[1*]OC(=O)C(C)CC(C)(CC(CC)C(=O)O[3*])C(=O)O[2*] Chemical compound *.B.C.[1*]OC(=O)C(C)CC(C)(CC(CC)C(=O)O[3*])C(=O)O[2*] 0.000 description 1
- ZLCUIOWQYBYEBG-UHFFFAOYSA-N 1-Amino-2-methylanthraquinone Chemical compound C1=CC=C2C(=O)C3=C(N)C(C)=CC=C3C(=O)C2=C1 ZLCUIOWQYBYEBG-UHFFFAOYSA-N 0.000 description 1
- JWYVGKFDLWWQJX-UHFFFAOYSA-N 1-ethenylazepan-2-one Chemical compound C=CN1CCCCCC1=O JWYVGKFDLWWQJX-UHFFFAOYSA-N 0.000 description 1
- PBGPBHYPCGDFEZ-UHFFFAOYSA-N 1-ethenylpiperidin-2-one Chemical compound C=CN1CCCCC1=O PBGPBHYPCGDFEZ-UHFFFAOYSA-N 0.000 description 1
- 239000012956 1-hydroxycyclohexylphenyl-ketone Substances 0.000 description 1
- AFXKUUDFKHVAGI-UHFFFAOYSA-N 1-methyl-3-methylidenepyrrolidin-2-one Chemical compound CN1CCC(=C)C1=O AFXKUUDFKHVAGI-UHFFFAOYSA-N 0.000 description 1
- VBHXIMACZBQHPX-UHFFFAOYSA-N 2,2,2-trifluoroethyl prop-2-enoate Chemical compound FC(F)(F)COC(=O)C=C VBHXIMACZBQHPX-UHFFFAOYSA-N 0.000 description 1
- PLXOUIVCSUBZIX-UHFFFAOYSA-N 2,2,3,3,4,4,4-heptafluorobutyl prop-2-enoate Chemical compound FC(F)(F)C(F)(F)C(F)(F)COC(=O)C=C PLXOUIVCSUBZIX-UHFFFAOYSA-N 0.000 description 1
- WISUNKZXQSKYMR-UHFFFAOYSA-N 2,2,3,3,4,4,5,5-octafluoropentyl prop-2-enoate Chemical compound FC(F)C(F)(F)C(F)(F)C(F)(F)COC(=O)C=C WISUNKZXQSKYMR-UHFFFAOYSA-N 0.000 description 1
- RPHIWWKRMBRETN-UHFFFAOYSA-N 2,2,3,3,4,4-hexafluorobutyl prop-2-enoate Chemical compound FC(F)C(F)(F)C(F)(F)COC(=O)C=C RPHIWWKRMBRETN-UHFFFAOYSA-N 0.000 description 1
- VHJHZYSXJKREEE-UHFFFAOYSA-N 2,2,3,3-tetrafluoropropyl prop-2-enoate Chemical compound FC(F)C(F)(F)COC(=O)C=C VHJHZYSXJKREEE-UHFFFAOYSA-N 0.000 description 1
- LMVLEDTVXAGBJV-UHFFFAOYSA-N 2,2,3,4,4,4-hexafluorobutyl prop-2-enoate Chemical compound FC(F)(F)C(F)C(F)(F)COC(=O)C=C LMVLEDTVXAGBJV-UHFFFAOYSA-N 0.000 description 1
- GOXQRTZXKQZDDN-UHFFFAOYSA-N 2-Ethylhexyl acrylate Chemical compound CCCCC(CC)COC(=O)C=C GOXQRTZXKQZDDN-UHFFFAOYSA-N 0.000 description 1
- WYGWHHGCAGTUCH-UHFFFAOYSA-N 2-[(2-cyano-4-methylpentan-2-yl)diazenyl]-2,4-dimethylpentanenitrile Chemical compound CC(C)CC(C)(C#N)N=NC(C)(C#N)CC(C)C WYGWHHGCAGTUCH-UHFFFAOYSA-N 0.000 description 1
- ZCDADJXRUCOCJE-UHFFFAOYSA-N 2-chlorothioxanthen-9-one Chemical compound C1=CC=C2C(=O)C3=CC(Cl)=CC=C3SC2=C1 ZCDADJXRUCOCJE-UHFFFAOYSA-N 0.000 description 1
- SJEBAWHUJDUKQK-UHFFFAOYSA-N 2-ethylanthraquinone Chemical compound C1=CC=C2C(=O)C3=CC(CC)=CC=C3C(=O)C2=C1 SJEBAWHUJDUKQK-UHFFFAOYSA-N 0.000 description 1
- XMLYCEVDHLAQEL-UHFFFAOYSA-N 2-hydroxy-2-methyl-1-phenylpropan-1-one Chemical compound CC(C)(O)C(=O)C1=CC=CC=C1 XMLYCEVDHLAQEL-UHFFFAOYSA-N 0.000 description 1
- ZWVHTXAYIKBMEE-UHFFFAOYSA-N 2-hydroxyacetophenone Chemical class OCC(=O)C1=CC=CC=C1 ZWVHTXAYIKBMEE-UHFFFAOYSA-N 0.000 description 1
- VGKYEIFFSOPYEW-UHFFFAOYSA-N 2-methyl-4-[(4-phenyldiazenylphenyl)diazenyl]phenol Chemical compound Cc1cc(ccc1O)N=Nc1ccc(cc1)N=Nc1ccccc1 VGKYEIFFSOPYEW-UHFFFAOYSA-N 0.000 description 1
- CEXQWAAGPPNOQF-UHFFFAOYSA-N 2-phenoxyethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCOC1=CC=CC=C1 CEXQWAAGPPNOQF-UHFFFAOYSA-N 0.000 description 1
- UWRZIZXBOLBCON-UHFFFAOYSA-N 2-phenylethenamine Chemical compound NC=CC1=CC=CC=C1 UWRZIZXBOLBCON-UHFFFAOYSA-N 0.000 description 1
- XLLXMBCBJGATSP-UHFFFAOYSA-N 2-phenylethenol Chemical compound OC=CC1=CC=CC=C1 XLLXMBCBJGATSP-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- FRIBMENBGGCKPD-UHFFFAOYSA-N 3-(2,3-dimethoxyphenyl)prop-2-enal Chemical compound COC1=CC=CC(C=CC=O)=C1OC FRIBMENBGGCKPD-UHFFFAOYSA-N 0.000 description 1
- QPQKUYVSJWQSDY-UHFFFAOYSA-N 4-phenyldiazenylaniline Chemical compound C1=CC(N)=CC=C1N=NC1=CC=CC=C1 QPQKUYVSJWQSDY-UHFFFAOYSA-N 0.000 description 1
- BMVWCPGVLSILMU-UHFFFAOYSA-N 5,6-dihydrodibenzo[2,1-b:2',1'-f][7]annulen-11-one Chemical compound C1CC2=CC=CC=C2C(=O)C2=CC=CC=C21 BMVWCPGVLSILMU-UHFFFAOYSA-N 0.000 description 1
- JTHZUSWLNCPZLX-UHFFFAOYSA-N 6-fluoro-3-methyl-2h-indazole Chemical compound FC1=CC=C2C(C)=NNC2=C1 JTHZUSWLNCPZLX-UHFFFAOYSA-N 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- GAWIXWVDTYZWAW-UHFFFAOYSA-N C[CH]O Chemical group C[CH]O GAWIXWVDTYZWAW-UHFFFAOYSA-N 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 206010051819 Cyanopsia Diseases 0.000 description 1
- 239000004641 Diallyl-phthalate Substances 0.000 description 1
- 229920005177 Duracon® POM Polymers 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 244000028419 Styrax benzoin Species 0.000 description 1
- 235000000126 Styrax benzoin Nutrition 0.000 description 1
- 235000008411 Sumatra benzointree Nutrition 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- SQPVWJZAHUFSJY-UHFFFAOYSA-N [2,3,4,5,5,5-hexafluoro-2,4-bis(trifluoromethyl)pentyl] prop-2-enoate Chemical compound FC(F)(F)C(F)(C(F)(F)F)C(F)C(F)(C(F)(F)F)COC(=O)C=C SQPVWJZAHUFSJY-UHFFFAOYSA-N 0.000 description 1
- 229920000800 acrylic rubber Polymers 0.000 description 1
- 125000003647 acryloyl group Chemical group O=C([*])C([H])=C([H])[H] 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- WURBFLDFSFBTLW-UHFFFAOYSA-N benzil Chemical compound C=1C=CC=CC=1C(=O)C(=O)C1=CC=CC=C1 WURBFLDFSFBTLW-UHFFFAOYSA-N 0.000 description 1
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 1
- 229960002130 benzoin Drugs 0.000 description 1
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical compound C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- 150000001565 benzotriazoles Chemical class 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- ZPOLOEWJWXZUSP-AATRIKPKSA-N bis(prop-2-enyl) (e)-but-2-enedioate Chemical compound C=CCOC(=O)\C=C\C(=O)OCC=C ZPOLOEWJWXZUSP-AATRIKPKSA-N 0.000 description 1
- QUDWYFHPNIMBFC-UHFFFAOYSA-N bis(prop-2-enyl) benzene-1,2-dicarboxylate Chemical compound C=CCOC(=O)C1=CC=CC=C1C(=O)OCC=C QUDWYFHPNIMBFC-UHFFFAOYSA-N 0.000 description 1
- FPODCVUTIPDRTE-UHFFFAOYSA-N bis(prop-2-enyl) hexanedioate Chemical compound C=CCOC(=O)CCCCC(=O)OCC=C FPODCVUTIPDRTE-UHFFFAOYSA-N 0.000 description 1
- MQDJYUACMFCOFT-UHFFFAOYSA-N bis[2-(1-hydroxycyclohexyl)phenyl]methanone Chemical compound C=1C=CC=C(C(=O)C=2C(=CC=CC=2)C2(O)CCCCC2)C=1C1(O)CCCCC1 MQDJYUACMFCOFT-UHFFFAOYSA-N 0.000 description 1
- OCWYEMOEOGEQAN-UHFFFAOYSA-N bumetrizole Chemical compound CC(C)(C)C1=CC(C)=CC(N2N=C3C=C(Cl)C=CC3=N2)=C1O OCWYEMOEOGEQAN-UHFFFAOYSA-N 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- KBLWLMPSVYBVDK-UHFFFAOYSA-N cyclohexyl prop-2-enoate Chemical compound C=CC(=O)OC1CCCCC1 KBLWLMPSVYBVDK-UHFFFAOYSA-N 0.000 description 1
- BTQLDZMOTPTCGG-UHFFFAOYSA-N cyclopentyl prop-2-enoate Chemical compound C=CC(=O)OC1CCCC1 BTQLDZMOTPTCGG-UHFFFAOYSA-N 0.000 description 1
- FWLDHHJLVGRRHD-UHFFFAOYSA-N decyl prop-2-enoate Chemical compound CCCCCCCCCCOC(=O)C=C FWLDHHJLVGRRHD-UHFFFAOYSA-N 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 125000004990 dihydroxyalkyl group Chemical group 0.000 description 1
- 125000005442 diisocyanate group Chemical group 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 239000000986 disperse dye Substances 0.000 description 1
- GMSCBRSQMRDRCD-UHFFFAOYSA-N dodecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)=C GMSCBRSQMRDRCD-UHFFFAOYSA-N 0.000 description 1
- MCPKSFINULVDNX-UHFFFAOYSA-N drometrizole Chemical compound CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 MCPKSFINULVDNX-UHFFFAOYSA-N 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 150000002148 esters Chemical group 0.000 description 1
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 description 1
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 150000002237 fumaric acid derivatives Chemical class 0.000 description 1
- 235000019382 gum benzoic Nutrition 0.000 description 1
- SCFQUKBBGYTJNC-UHFFFAOYSA-N heptyl prop-2-enoate Chemical compound CCCCCCCOC(=O)C=C SCFQUKBBGYTJNC-UHFFFAOYSA-N 0.000 description 1
- LNMQRPPRQDGUDR-UHFFFAOYSA-N hexyl prop-2-enoate Chemical compound CCCCCCOC(=O)C=C LNMQRPPRQDGUDR-UHFFFAOYSA-N 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- PBOSTUDLECTMNL-UHFFFAOYSA-N lauryl acrylate Chemical compound CCCCCCCCCCCCOC(=O)C=C PBOSTUDLECTMNL-UHFFFAOYSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 150000002688 maleic acid derivatives Chemical class 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 125000005395 methacrylic acid group Chemical group 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- JESXATFQYMPTNL-UHFFFAOYSA-N mono-hydroxyphenyl-ethylene Natural products OC1=CC=CC=C1C=C JESXATFQYMPTNL-UHFFFAOYSA-N 0.000 description 1
- MDYPDLBFDATSCF-UHFFFAOYSA-N nonyl prop-2-enoate Chemical compound CCCCCCCCCOC(=O)C=C MDYPDLBFDATSCF-UHFFFAOYSA-N 0.000 description 1
- QUAMTGJKVDWJEQ-UHFFFAOYSA-N octabenzone Chemical compound OC1=CC(OCCCCCCCC)=CC=C1C(=O)C1=CC=CC=C1 QUAMTGJKVDWJEQ-UHFFFAOYSA-N 0.000 description 1
- KCAMXZBMXVIIQN-UHFFFAOYSA-N octan-3-yl 2-methylprop-2-enoate Chemical compound CCCCCC(CC)OC(=O)C(C)=C KCAMXZBMXVIIQN-UHFFFAOYSA-N 0.000 description 1
- 229940065472 octyl acrylate Drugs 0.000 description 1
- ANISOHQJBAQUQP-UHFFFAOYSA-N octyl prop-2-enoate Chemical compound CCCCCCCCOC(=O)C=C ANISOHQJBAQUQP-UHFFFAOYSA-N 0.000 description 1
- 150000002923 oximes Chemical class 0.000 description 1
- DXGLGDHPHMLXJC-UHFFFAOYSA-N oxybenzone Chemical compound OC1=CC(OC)=CC=C1C(=O)C1=CC=CC=C1 DXGLGDHPHMLXJC-UHFFFAOYSA-N 0.000 description 1
- GOZDOXXUTWHSKU-UHFFFAOYSA-N pentadecyl prop-2-enoate Chemical compound CCCCCCCCCCCCCCCOC(=O)C=C GOZDOXXUTWHSKU-UHFFFAOYSA-N 0.000 description 1
- ULDDEWDFUNBUCM-UHFFFAOYSA-N pentyl prop-2-enoate Chemical compound CCCCCOC(=O)C=C ULDDEWDFUNBUCM-UHFFFAOYSA-N 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- WRAQQYDMVSCOTE-UHFFFAOYSA-N phenyl prop-2-enoate Chemical compound C=CC(=O)OC1=CC=CC=C1 WRAQQYDMVSCOTE-UHFFFAOYSA-N 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 230000000379 polymerizing effect Effects 0.000 description 1
- 229920006324 polyoxymethylene Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- PNXMTCDJUBJHQJ-UHFFFAOYSA-N propyl prop-2-enoate Chemical compound CCCOC(=O)C=C PNXMTCDJUBJHQJ-UHFFFAOYSA-N 0.000 description 1
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000009864 tensile test Methods 0.000 description 1
- CIHOLLKRGTVIJN-UHFFFAOYSA-N tert‐butyl hydroperoxide Chemical compound CC(C)(C)OO CIHOLLKRGTVIJN-UHFFFAOYSA-N 0.000 description 1
- YRHRIQCWCFGUEQ-UHFFFAOYSA-N thioxanthen-9-one Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3SC2=C1 YRHRIQCWCFGUEQ-UHFFFAOYSA-N 0.000 description 1
- 239000000984 vat dye Substances 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/16—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/26—Esters containing oxygen in addition to the carboxy oxygen
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/26—Esters containing oxygen in addition to the carboxy oxygen
- C08F220/28—Esters containing oxygen in addition to the carboxy oxygen containing no aromatic rings in the alcohol moiety
- C08F220/281—Esters containing oxygen in addition to the carboxy oxygen containing no aromatic rings in the alcohol moiety and containing only one oxygen, e.g. furfuryl (meth)acrylate or 2-methoxyethyl (meth)acrylate
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/26—Esters containing oxygen in addition to the carboxy oxygen
- C08F220/30—Esters containing oxygen in addition to the carboxy oxygen containing aromatic rings in the alcohol moiety
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F222/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides, or nitriles thereof
- C08F222/10—Esters
- C08F222/12—Esters of phenols or saturated alcohols
- C08F222/14—Esters having no free carboxylic acid groups, e.g. dialkyl maleates or fumarates
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
- G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
- G02B1/041—Lenses
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B1/00—Optical elements characterised by the material of which they are made; Optical coatings for optical elements
- G02B1/04—Optical elements characterised by the material of which they are made; Optical coatings for optical elements made of organic materials, e.g. plastics
- G02B1/041—Lenses
- G02B1/043—Contact lenses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/16—Materials or treatment for tissue regeneration for reconstruction of eye parts, e.g. intraocular lens, cornea
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/26—Esters containing oxygen in addition to the carboxy oxygen
- C08F220/28—Esters containing oxygen in addition to the carboxy oxygen containing no aromatic rings in the alcohol moiety
- C08F220/285—Esters containing oxygen in addition to the carboxy oxygen containing no aromatic rings in the alcohol moiety and containing a polyether chain in the alcohol moiety
- C08F220/286—Esters containing oxygen in addition to the carboxy oxygen containing no aromatic rings in the alcohol moiety and containing a polyether chain in the alcohol moiety and containing polyethylene oxide in the alcohol moiety, e.g. methoxy polyethylene glycol (meth)acrylate
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/26—Esters containing oxygen in addition to the carboxy oxygen
- C08F220/30—Esters containing oxygen in addition to the carboxy oxygen containing aromatic rings in the alcohol moiety
- C08F220/301—Esters containing oxygen in addition to the carboxy oxygen containing aromatic rings in the alcohol moiety and one oxygen in the alcohol moiety
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F222/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by a carboxyl radical and containing at least one other carboxyl radical in the molecule; Salts, anhydrides, esters, amides, imides, or nitriles thereof
- C08F222/10—Esters
- C08F222/12—Esters of phenols or saturated alcohols
- C08F222/14—Esters having no free carboxylic acid groups, e.g. dialkyl maleates or fumarates
- C08F222/145—Esters having no free carboxylic acid groups, e.g. dialkyl maleates or fumarates the ester chains containing seven or more carbon atoms
-
- C08F2220/286—
Definitions
- the present invention relates to an intraocular lens material.
- One previously proposed intraocular lens material is a polymer obtained by polymerizing polymerizable components including a hydrophilic monomer such as a hydroxyl group-containing alkyl (meth)acrylate, a (meth)acrylamide monomer, or an N-vinyl lactam, and the water absorption percentage of the intraocular lens material is 1.5 to 4.5% by mass (see, for example, PTL 1).
- This intraocular lens material is excellent in flexibility and has a high refractive index. Therefore, a lens with a reduced thickness can be provided, and the lens in a folded state can be inserted through an incision. Moreover, the intraocular lens material has excellent transparency and can reduce the occurrence of glistening.
- ester moieties may undergo hydrolysis, and dissolution of a hydrolysate may occur although the amount of dissolution is very small. There is therefore a need for a material that can provide an intraocular lens from which only a reduced amount of a hydrolysate dissolves.
- the present invention has been made in view of the foregoing circumstances, and it is a primary object to provide an intraocular lens material from which only a reduced amount of the hydrolysate dissolves in an aqueous solution.
- the present inventors have conducted extensive studies and found that, when an intraocular lens material containing an acrylate as a base material contains a specific methacrylate, the amount of a hydrolysate dissolved in an aqueous solution can be further reduced while the desired properties of the intraocular lens material are maintained or improved. Thus, the present invention has been completed.
- an intraocular lens material disclosed in the present description comprises: an aromatic ring-containing acrylate structural unit; an alkoxyalkyl methacrylate structural unit including an alkoxyalkyl group having 4 or less carbon atoms; a hydrophilic structural unit based on a hydrophilic monomer; and a cross-linking structural unit based on a cross-linkable monomer.
- the amount of a hydrolysate dissolved from the intraocular lens material in an aqueous solution can be further reduced.
- the reason that this effect is obtained may be, for example, as follows.
- methacrylate is a material harder than acrylate because of the presence of a methyl group but may resist attack by water. Therefore, hydrolysis resistance may be improved.
- the alkoxyalkyl group having 4 or less carbon atoms is included, the number of carbon atoms is preferable, and therefore the intraocular lens material may not be excessively hard and may have sufficient flexibility.
- the intraocular lens material containing the alkoxyalkyl group having 4 or less carbon atoms may be preferred in terms of flexibility, reduction in stickiness, and the ability to reduce the occurrence of glistening.
- the alkoxyalkyl group may be represented by, for example, chemical formula (1).
- FIG. 1 is a side view of an indenter 10 and a jig 11 that are used for compressive load measurement.
- FIG. 2 is an illustration of a specimen used for elongation percentage measurement.
- An intraocular lens material disclosed in an embodiment comprises: an aromatic ring-containing acrylate structural unit; an alkoxyalkyl methacrylate structural unit including an alkoxyalkyl group having 4 or less carbon atoms; a hydrophilic structural unit based on a hydrophilic monomer; and a cross-linking structural unit based on a cross-linkable monomer.
- This intraocular lens material contains, as a base material, the aromatic ring-containing acrylate structural unit and the alkoxyalkyl methacrylate structural unit including the alkoxyalkyl group having 4 or less carbon atoms.
- the intraocular lens material may further contain, as a base material, an alkyl acrylate structural unit including an alkyl group having 1 to 20 carbon atoms.
- the base material is component forming the main structure of the intraocular lens material.
- the intraocular lens material may contain, as a base material, aromatic ring-containing acrylate structural units A, alkoxyalkyl methacrylate structural units B, and alkyl acrylate structural units C.
- a, b, and c are any integers.
- the aromatic ring-containing acrylate structural units A, the alkoxyalkyl methacrylate structural units B, and the alkyl acrylate structural units C are bonded to a carbon chain in an arbitrary manner, and adjacent structural units may be the same or different.
- a functional group R 1 is an aromatic ring-containing functional group
- a functional group R 2 is an alkoxyalkyl group including an alkoxy group and having 4 or less carbon atoms.
- a functional group R 3 is an alkyl group having 1 to 20 carbon atoms.
- acrylate having an acryloyl group and methacrylate having a methacryloyl group are collectively referred to as “(meth)acrylate.”
- a structural unit included in a polymer is designated by the name of a corresponding monomer.
- Monomers exemplified in the description of a polymer structure have structures in which their polymerizable groups are bonded to other structural units.
- a monomer exemplified as “(meth)acrylate” in the description of a polymer structure is present as a “(meth)acrylate structural unit” in the polymer.
- this structural unit another structural unit is bonded (polymerized) to a double bond of the (meth) acrylate.
- the aromatic ring-containing acrylate structural unit is a structural unit based on an aromatic ring-containing acrylate used as a base material monomer.
- This aromatic ring-containing acrylate may be a component having the function of increasing the refractive index of the intraocular lens material.
- This aromatic ring-containing acrylate structural unit may have a phenoxy group, an alkylene group having 2 or less carbon atoms, and an acrylate bond moiety. Examples of the aromatic ring-containing acrylate include phenoxyethyl acrylate, phenylethyl acrylate, benzyl acrylate, phenyl acrylate, and pentabromophenyl acrylate.
- the amount of the aromatic ring-containing acrylate is within the range of from 15 parts by mass to 80 parts by mass inclusive based on 100 parts by mass of the total amount of the base material.
- the amount of the aromatic ring-containing acrylate is from 30 parts by mass to 80 parts by mass inclusive based on 100 parts of the base material because it is desirable that the intraocular lens material has a high refractive index even in a moistened state.
- the alkoxyalkyl methacrylate structural unit including the alkoxyalkyl group having 4 or less carbon atoms is a structural unit based on an alkoxyalkyl methacrylate used as a base material monomer.
- the alkoxyalkyl group in the alkoxyalkyl methacrylate may be, for example, a group represented by chemical formula (1) above.
- Examples of the alkoxy group include a methoxy group and an ethoxy group.
- Examples of the alkylene group to which the alkoxy group is bonded include a methylene group and an ethylene group.
- the alkoxyalkyl methacrylate is preferably at least one of methoxyethyl methacrylate and ethoxyethyl methacrylate and more preferably ethoxyethyl methacrylate.
- the amount of the alkoxyalkyl methacrylate is preferably within the range of from 10 parts by mass to 70 parts by mass inclusive based on 100 parts by mass of the total amount of the base material. From the viewpoint that the degree of hydrolysis can be further reduced and from the viewpoint of ease of folding, the amount of the alkoxyalkyl methacrylate is more preferably from 20 parts by mass to 40 parts by mass inclusive based on 100 parts by mass of the base material.
- An example of the structure of the intraocular lens material is shown in chemical formula (3).
- the base material is 2-phenoxyethyl acrylate (POEA), ethyl acrylate (EA), and ethoxyethyl methacrylate (ETMA).
- POEA 2-phenoxyethyl acrylate
- EA ethyl acrylate
- ETMA ethoxyethyl methacrylate
- a, b, and c are any integers.
- the aromatic ring-containing acrylate structural units A, the alkoxyalkyl methacrylate structural units B, and the alkyl acrylate structural units C are bonded to a carbon chain in an arbitrary manner, and adjacent structural units may be the same or different.
- the alkyl acrylate structural unit including the alkyl group having 1 to 20 carbon atoms is a structural unit based on an alkyl acrylate used as a base material monomer.
- the alkyl acrylate including the alkyl group having 1 to 20 carbon atoms may be a component having the function of improving the shape recoverability and flexibility of the intraocular lens material.
- alkyl acrylate examples include straight-chain, branched-chain, and cyclic alkyl acrylates such as methyl acrylate, ethyl acrylate, propyl acrylate, butyl acrylate, pentyl acrylate, hexyl acrylate, heptyl acrylate, nonyl acrylate, stearyl acrylate, octyl acrylate, decyl acrylate, lauryl acrylate, pentadecyl acrylate, 2-ethylhexyl acrylate, cyclopentyl acrylate, and cyclohexyl acrylate.
- alkyl acrylate examples include straight-chain, branched-chain, and cyclic alkyl acrylates such as methyl acrylate, ethyl acrylate, propyl acrylate, butyl acrylate, pentyl acrylate, hexyl acrylate, heptyl
- alkyl acrylate examples include fluorine-containing alkyl (meth)acrylates such as 2,2,2-trifluoroethyl acrylate, 2,2,3,3-tetrafluoropropyl acrylate, 2,2,3,3-tetrafluoro-t-pentyl acrylate, 2,2,3,4,4,4-hexafluorobutyl acrylate, 2,2,3,4,4,4-hexafluoro-t-hexyl acrylate, 2,3,4,5,5,5-hexafluoro-2,4-bis(trifluoromethyl)pentyl acrylate, 2,2,3,3,4,4-hexafluorobutyl acrylate, 2,2,2,2′,2′,2′-hexafluoroisopropyl acrylate, 2,2,3,3,4,4,4-heptafluorobutyl acrylate, and 2,2,3,3,4,4,5,5-octafluoropentyl acrylate.
- alkyl acrylates including an alkyl group having 1 to 5 carbon atoms are preferred because their effect of improving the shape recoverability and flexibility is high, and ethyl acrylate and butyl acrylate are particularly preferably used.
- the amount of the alkyl acrylate is within the range of from 0 parts by mass to 35 parts by mass inclusive based on 100 parts by mass of the total amount of the base material.
- the alkyl acrylate is regarded as one of the base material but is not necessarily an essential component. In terms of the flexibility and shape recoverability, the amount of the alkyl acrylate may be appropriately adjusted at the above ratio.
- the hydrophilic structural unit is a structural unit based on a hydrophilic monomer.
- the hydrophilic monomer is a component that provides hydrophilicity to the intraocular lens material and may be a component having the function of facilitating a reduction in the occurrence of glistening in the intraocular lens material.
- the hydrophilic monomer may include, for example, at least one of hydroxyl group-containing alkyl (meth)acrylates including an alkyl group having 1 to 20 carbon atoms, (meth)acrylamide monomers, and N-vinyl lactams.
- An additional hydrophilic monomer other than the above hydrophilic monomers may be included.
- hydroxyl group-containing alkyl (meth)acrylate examples include: hydroxyalkyl (meth)acrylates such as hydroxyethyl (meth) acrylate, hydroxypropyl (meth) acrylate, hydroxybutyl (meth)acrylate, and hydroxypentyl (meth)acrylate; and dihydroxyalkyl (meth)acrylates such as dihydroxypropyl (meth)acrylate, dihydroxybutyl (meth)acrylate, and dihydroxypentyl (meth)acrylate.
- hydroxyalkyl (meth)acrylates such as hydroxyethyl (meth) acrylate, hydroxypropyl (meth) acrylate, hydroxybutyl (meth)acrylate, and hydroxypentyl (meth)acrylate
- dihydroxyalkyl (meth)acrylates such as dihydroxypropyl (meth)acrylate, dihydroxybutyl (meth)acrylate, and dihydroxypentyl (meth)acryl
- Examples of the (meth)acrylamide monomer include N,N-dialkyl(meth)acrylamides such as N,N-dimethyl(meth)acrylamide, N,N-diethyl(meth)acrylamide, and N,N-dipropyl(meth)acrylamide; and N,N-dialkylaminoalkyl(meth)acrylamides such as N,N-dimethylaminopropyl(meth)acrylamide and N,N-diethylaminopropyl(meth)acrylamide.
- Examples of the N-vinyl lactam include N-vinylpyrrolidone, N-vinylpiperidone, and N-vinylcaprolactam.
- hydrophilic monomer examples include diethylene glycol mono(meth)acrylate, triethylene glycol mono(meth)acrylate, propylene glycol mono(meth)acrylate, (meth)acrylic acid, 1-methyl-3-methylene-2-pyrrolidinone, maleic anhydride, maleic acid, maleic acid derivatives, fumaric acid, fumaric acid derivatives, aminostyrene, and hydroxystyrene.
- the above-described hydrophilic monomers may be used alone, or a mixture of two or more may be used.
- hydrophilic monomers hydroxyl group-containing alkyl (meth)acrylates and (meth)acrylamide monomers are preferred because their function of facilitating a reduction in the occurrence of glistening is high, and 2-hydroxyethyl methacrylate is particularly preferred.
- the content of the hydrophilic monomer is within the range of from 15 parts by mass to 35 parts by mass inclusive by the outside ratio based on 100 parts by mass of the total amount of the base material. When the content of the hydrophilic monomer is within this range, the effect of facilitating a reduction in the occurrence of glistening can be sufficiently obtained, and no significant burden and difficulty arise when the intraocular lens material in a dry state is folded.
- the cross-linking structural unit is a structural unit based on a cross-linkable monomer.
- the cross-linkable monomer may be a component that has the function of controlling the flexibility of the intraocular lens material, the function of imparting good mechanical properties, the function of further improving the shape recoverability, and the function of improving copolymerizability of the polymerizable components such as the hydrophilic monomer and other polymerizable monomers.
- cross-linkable monomer examples include butanediol di(meth)acrylate, ethylene glycol di(meth)acrylate, diethylene glycol di(meth)acrylate, triethylene glycol di(meth)acrylate, propylene glycol di(meth)acrylate, dipropylene glycol di(meth)acrylate, diallyl fumarate, allyl (meth)acrylate, vinyl (meth)acrylate, trimethylolpropane tri(meth)acrylate, methacryloyloxyethyl (meth)acrylate, divinylbenzene, diallyl phthalate, diallyl adipate, triallyl diisocyanate, ⁇ -methylene-N-vinylpyrrolidone, 4-vinylbenzyl (meth)acrylate, 3-vinylbenzyl (meth)acrylate, 2,2-bis((meth)acryloyloxyphenyl)hexafluoropropane, 2,2-bis((meth
- the content of the cross-linkable monomer is within the range of from 2 parts by mass to 4 parts by mass inclusive by the outside ratio based on 100 parts by mass of the total amount of the base material.
- the content is preferably 2 parts by mass or more from the viewpoint of imparting the shape recoverability and reducing the occurrence of glistening.
- the content is preferably 4 parts by mass or less because the intraocular lens material can have an elongation percentage high enough to allow insertion from a small incision.
- the intraocular lens material may contain other additional components such as an ultraviolet absorber and a coloring agent.
- the ultraviolet absorber include: benzophenones such as 2-hydroxy-4-methoxybenzophenone and 2-hydroxy-4-octoxybenzophenone; benzotriazoles such as 2-(2′-hydroxy-5′-methacryloxyethyleneoxy-t-butylphenyl)-5-methyl-benzotriazole, 2-(2′-hydroxy-5′-methylphenyl)benzotriazole, and 5-chloro-2(3′-t-butyl-2′-hydroxy-5′-methylphenyl)benzotriazole; salicylic acid derivatives; and hydroxyacetophenone derivatives.
- the amount of the ultraviolet absorber added is, for example, within the range of from 0.05 parts by mass to 3 parts by mass inclusive by the outside ratio based on 100 parts by mass of the total amount of the base material.
- a yellow or orange coloring agent examples include: a dye described in Japanese Unexamined Patent Application Publication No. 2006-291006; oil-soluble dyes such as CI Solvent Yellow and CI Solvent Orange listed in the Color Index International (CI); disperse dyes such as CI Disperse Yellow and CI Disperse Orange listed in the Color Index International (CI); and vat dyes.
- the amount of the coloring agent added is within the range of from 0.01 parts by mass to 3 parts by mass inclusive by the outside ratio based on 100 parts by mass of the total amount of the base material.
- a radical polymerization initiator or a photopolymerization initiator may be added for polymerization to obtain the intraocular lens material.
- a polymerization method in which a radical polymerization initiator is added followed by heating or irradiation with electromagnetic waves such as microwaves, ultraviolet radiation, or radiation ( ⁇ radiation) may be used.
- the radical polymerization initiator include azobisisobutyronitrile, azobisdimethylvaleronitrile, benzoyl peroxide, t-butyl hydroperoxide, and cumene hydroperoxide.
- a light beam for example, it is preferable to further add a photopolymerization initiator or a sensitizer.
- photopolymerization initiator examples include: benzoin-based compounds such as methyl orthobenzoyl benzoate; phenone-based compounds such as 2-hydroxy-2-methyl-1-phenylpropane-1-one; thioxanthone-based compounds such as 1-hydroxycyclohexyl phenyl ketone, 1-phenyl-1,2-propanedione-2-(o-ethoxycarbonyl)oxime, and 2-chlorothioxanthone; dibenzosuberone; 2-ethylanthraquinone; benzophenone acrylate; benzophenone; and benzil.
- benzoin-based compounds such as methyl orthobenzoyl benzoate
- phenone-based compounds such as 2-hydroxy-2-methyl-1-phenylpropane-1-one
- thioxanthone-based compounds such as 1-hydroxycyclohexyl phenyl ketone, 1-phenyl-1,2-propanedione-2-(o-e
- the amount of the polymerization initiator or sensitizer used is preferably within the range of from 0.01 parts by mass to 2 parts by mass inclusive by the outside ratio based on 100 parts by mass of the total amount of the base material.
- the intraocular lens material of the present invention may be formed into an intraocular lens using, for example, lathing or molding.
- the number of glistening spots per a lens is preferably 15 or less.
- the number of glistening spots per a plate is preferably 6 or less and more preferably 2 or less.
- the intraocular lens material has an elongation percentage high enough to allow insertion from a small incision. Specifically, when the material is evaluated using an experimental method described in the present description, the elongation percentage is preferably 170% or more. In terms of the shape recoverability of the intraocular lens material, the elongation percentage is preferably 600% or less.
- the dissolution rate of phenoxyethyl alcohol (POEtOH), which is a hydrolysate of the material, after the material has been stored in water at 100° C. for 30 days is preferably 0.13% by mass or less and more preferably 0.10% by mass or less.
- the dissolution rate of POEtOH from the material after the material has been stored in water at 100° C. for 60 days is preferably 0.80% by mass or less and more preferably 0.70% by mass or less.
- the dissolution rate of POEtOH from the material after the material has been stored in water at 100° C. for 90 days is preferably 3.30% by mass or less and more preferably 2.80% by mass or less. The smaller the dissolution rate, the more preferred.
- the water absorption percentage (% by mass) of the material is preferably within the range of from 1.5% by mass to 4.5% by mass inclusive.
- the water absorption percentage is 1.5% by mass or more, the occurrence of glistening can be reduced.
- the water absorption percentage is 4.5% by mass or less, a reduction in flexibility and a reduction in shape recoverability can be suppressed.
- the intraocular lens material of the present invention is excellent in flexibility and has a high refractive index. Therefore, a lens with a reduced thickness can be provided, and the lens in a folded state can be inserted through a small incision.
- the intraocular lens material has excellent transparency and can reduce the occurrence of glistening.
- the amount of the hydrolysate dissolved from the intraocular lens material in an aqueous solution can be reduced.
- the alkoxyalkyl methacrylate including the alkoxyalkyl group having 4 or less carbon atoms is included in addition to the acrylates used as a base material.
- methacrylate is a material harder than acrylate because of the presence of a methyl group but resists attack by water, and therefore hydrolysis resistance may be improved. When the number of methacrylate structural units is increased, glistening often occurs easily.
- the alkoxyalkyl methacrylate is used as methacrylate, so that the ability to reduce the occurrence of glistening does not seem to be lost.
- the alkoxyalkyl methacrylate having 4 or less carbon atoms is preferred in terms of flexibility, reduction in stickiness, and the ability to reduce the occurrence of glistening.
- Experimental Examples 7 to 14, 18, 20, 21, 23, 24, 26 to 29, 31, 32, 34, 35, 37 to 43, 45 to 53, 55, 57, 59, and 60 correspond to Examples of the present invention.
- Experimental Examples 1 to 6, 15 to 17, 19, 22, 25, 30, 33, 36, 44, 54, 56, and 58 correspond to Comparative Examples.
- the present invention is not limited to the following Examples, and it will be appreciated that the invention can be embodied in various forms so long as they fall within the technical scope of the invention.
- Polymerizable components shown in Table 1 were mixed with 0.5 parts by mass of 2,2′-azobis(2,4-dimethylvaleronitrile) as a polymerization initiator by the outside ratio based on 100 parts by mass of the total amount of the base material.
- the mixture was poured into a mold having a desired lens shape.
- the mold was placed in an oven at 80° C., and the mixture was subjected to heat polymerization molding for 40 minutes.
- the polymer obtained was removed from the mold and subjected to elution treatment. Then the resulting polymer was dried in an oven at 60° C., and a lens-shaped intraocular lens material (one of Experimental Examples 1 to 14) was thereby obtained.
- a specimen was dried at 60° C. in advance, and its pre-treatment mass W 0 was measured.
- 50 mL of distilled water was placed in a 100 mL pressure bottle, and the specimen was immersed therein.
- the pressure bottle was placed in an incubator at 100° C. and stored therein.
- Ten plates with a diameter of 6 mm and a thickness of 0.5 mm were used as the specimen.
- the tare mass W 01 of the bottle, the mass W 02 of the bottle after the addition of distilled water, and the mass W 03 of the bottle after the immersion of the specimen were recorded.
- the concentration of phenoxyethyl alcohol (POEtOH, hydrolysate of POEA) in the extraction solution and the dissolution rate of POEtOH after 30 days of the hydrolysis treatment were determined using the following procedure.
- the mass W 11 of the bottle before collection of the extraction solution was recorded.
- the extraction solution was collected from the bottle, and the mass W 12 of the bottle after the collection of the extraction solution was recorded.
- the collected extraction solution, standard solutions, and a blank (distilled water) were analyzed using HPLC. After the analysis, the chromatogram of the distilled water was subtracted from the chromatograms of the collected extraction solution and the standard solutions to perform baseline correction. The area of the peak of POEtOH in each of the corrected chromatograms was calculated.
- a calibration curve was produced from the POEtOH concentrations and peak areas of the standard solutions.
- the concentration of POEtOH in the extraction solution was calculated using the area of the peak of POEtOH in the extraction solution and the calibration curve obtained.
- the dissolution rate of POEtOH per 1 g of the specimen was calculated from formula (1) below using the POEtOH concentration obtained.
- the volume of the extraction solution was calculated from formula (2).
- the volume of the extraction solution was calculated based on the following premises.
- the change in the mass of the specimen during heating at 100° C. is negligibly smaller than the change in the mass of the extraction solution. Since the most part of the extraction solution is water, the computation can be performed using 1 g/mL as the density of the extraction solution without any problem.
- the bottle was again placed in the incubator at 100° C. After a total of 60 days of the hydrolysis treatment, the extraction solution was again collected. The same procedure as that preformed after 30 days of the treatment was repeated. Specifically, the mass W 21 of the bottle before collection of the extraction solution was recorded. Then the concentration of POEtOH in the extraction solution was quantified by HPLC analysis, and the dissolution rate of POEtOH was calculated from formula (3). The volume of the extraction solution was calculated from formula (4). Similarly, the dissolution rate of POEtOH after a total of 90 days of the hydrolysis treatment was calculated.
- V 2S (mL ⁇ g) V 1S (mL ⁇ g) ⁇ [ W 11 (g) ⁇ W 12 (g)] ⁇ [ W 12 (g) ⁇ W 21 (g)]
- lens-shaped specimens with a diameter of 6 mm and a center thickness of 0.8 mm ⁇ 0.1 mm or plate specimens with a diameter of 6 mm and a thickness of 0.5 mm were used.
- the lens-shaped specimens were immersed in water at 35° C. for 17 hours or longer and then immersed in water at 25° C. for 2 hours, and the appearance was observed under a stereoscopic microscope.
- the plate specimens were immersed in water at 35° C. for 22 hours and then immersed in water at 25° C. for 2 hours, and the appearance was observed under a stereoscopic microscope.
- the observation of the appearance was performed on 2 or 3 specimens, and the number of glistening spots (bright spots) formed was examined.
- the magnification used was about 10 ⁇ to about 60 ⁇ . The magnification was appropriately adjusted within the above range so that the glistening was easily observed.
- the mass of each specimen in an equilibrium moisture state and its mass in a dry state were measured, and the water absorption percentage (mass %) of the specimen was calculated.
- the water absorption percentage was calculated from formula (5) below using the mass W w of the specimen in the equilibrium moisture state at 25° C. and the mass W d of the specimen in the dry state. Five plates with a diameter of 6 mm and a thickness of 0.8 mm were used as the specimens.
- the water absorption percentage (mass %) ( W w ⁇ W d )/ W d ⁇ 100 Formula (5)
- the refractive index of each specimen was determined using the Mercury e-line in an Abbe refractometer. The measurement was performed on the specimen in a dry state (25° C.) or a moisture state (35° C.). The specimen used was a plate with a diameter of 6 mm and a thickness of 0.8 mm.
- FIG. 1 is a side view of an indenter 10 and a jig 11 used for the measurement of the compressive load.
- Each of the indenter 10 and the jig 11 is made of polyoxymethylene (DURACON) and has a cylindrical shape.
- the indenter 10 and the jig 11 were attached to a creep meter (RE2-33005S manufactured by Yamaden Co., Ltd.).
- a double-sided adhesive tape (3M Scotch Brand Tape core series 2-0300) was attached to a specimen placement area on the upper surface of the jig 11 , and the specimen 12 was placed.
- a specimen stage (support) with the jig 11 attached thereto was moved up and down to bring the specimen 12 into contact with the indenter 10 .
- the specimen stage was moved up 3.2 mm from the contact position at a compression speed of 0.5 mm/sec to buckle the specimen.
- a load when the specimen stage was moved up 3 mm was used as the compressive load value.
- a plate with a diameter of 8 mm and a thickness of 0.8 mm was used.
- a jig for the stickiness measurement was attached to a specimen stage (support) of a creep meter. A part of the jig was detached, and the specimen was fitted into a part of the detached jig. Then the jig integrated with the specimen was attached to the creep meter. The specimen stage was moved to bring the specimen into contact with a metallic probe (radius of curvature: 2.5 mm) such that a force of 0.05 N was applied to the specimen, and the stage was stopped at this position.
- a metallic probe radius of curvature: 2.5 mm
- the specimen was separated from the probe at a separation speed of 1 mm/sec, and a load applied to the specimen was measured using the creep meter (RE2-33005S manufactured by Yamaden Co., Ltd.).
- a value of stickiness was calculated by subtracting the load after the probe had been separated from the specimen (the load after separation) from the maximum load measured.
- the stickiness value was 0 N or more and less than 0.16 N
- the specimen was rated “A”.
- the stickiness value was 0.16 N or more and less than 0.30 N
- the specimen was rated “B”.
- the stickiness value was 0.30 N or more, the specimen was rated “C”.
- Measurement was performed using a dumbbell-shaped specimen with a total length (L 0 ) of 20 mm, a parallel-portion length (L) of 6 mm, a parallel-portion width (W) of 1.5 mm, and a thickness of 0.8 mm (see FIG. 2 ).
- the specimen was immersed in water held at a constant temperature of 25° C., left to stand for 1 minute, and then pulled at a speed of 100 mm/min until break.
- the results for lens-shaped Experimental Examples 1 to 14 are shown in Table 5, and the results for plate-shaped Experimental Examples 15 to 60 are shown in Tables 6 to 9.
- the degree of hydrolysis can be reduced by increasing the number of methacrylate structural units, and alkoxymethacrylates are suitable for the methacrylate component.
- the amounts of acrylates (POEA and EA) used as a base material are less than those in the composition described in PTL 1, and POEMA, EHMA, or LMA is added.
- the materials of Experimental Examples 1 to 3 to which LMA was added the stickiness was high. Moreover, the materials were brittle and easily broken, and glistening occurred easily.
- a suitable amount of the alkoxymethacrylate added is preferably from 10 parts by mass to 70 parts by mass inclusive and more preferably from 20 parts by mass to 40 parts by mass inclusive based on 100 parts by mass of the base material.
- the minimum amount of the alkoxymethacrylate is preferably within the above range mainly from the viewpoint of the reduction in the degree of hydrolysis, and the maximum amount of the alkoxymethacrylate is preferably within the above range from the viewpoint of ease of folding and from the viewpoint that no significant burden and difficulty arise during folding.
- the amount of the aromatic ring-containing acrylate used as a base material is preferably 30 parts by mass or more based on 100 parts by mass of the base material from the viewpoint that the intraocular lens material in a hydrated state can have a refractive index of 1.50 or more. As the refractive index of the material increases, a thinner lens can be used to obtain a desired refractive power. The thinner the lens, the more easily the folded lens can be inserted into an eye.
- the amount of the hydrophilic monomer is preferably 15 parts by mass or more by the outside ratio based on 100 parts by mass of the total amount of the base material from the viewpoint of reducing the occurrence of glistening and is preferably 35 parts by mass or less by the outside ratio in order that no significant burden and difficulty arise during folding in a dry state.
- the compressive load in Table 8 is a value when the compressive load in Experimental Example 54 is set to 1. The material of Experimental Example 54 was evaluated in PTL 1, and the evaluation indicates that this material can be folded, but a large extra force is necessary.
- the amount of the cross-linkable monomer is preferably 2 parts by mass or more by the outside ratio based on 100 parts by mass of the total amount of the base material from the viewpoint of reducing the occurrence of glistening and from the viewpoint of shape recoverability after insertion into an eye and is preferably 4 parts by mass or less by the outside ratio in order to prevent the elongation of the material to be reduced so that the material does not break easily.
- the invention disclosed in the present description can be used for intraocular lens applications.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Transplantation (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- General Physics & Mathematics (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Materials For Medical Uses (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Prostheses (AREA)
- Eyeglasses (AREA)
Abstract
Description
- The present invention relates to an intraocular lens material.
- Progress in small-incision cataract surgery has led to the development of soft, flexible and foldable materials suitable for intraocular lenses. In particular, acrylic materials are desirable because they have a high refractive index and unfold slowly after insertion into an eye. However, when a material with enhanced shape recoverability is used for a lens, the elongation percentage of the lens becomes low. This material is brittle and easily torn when the lens has, for example, a flaw. To insert a lens into an eye through a minimum incision, it is preferable to use a material with a large elongation percentage so that the lens is prevented from cracking and tearing.
- One previously proposed intraocular lens material is a polymer obtained by polymerizing polymerizable components including a hydrophilic monomer such as a hydroxyl group-containing alkyl (meth)acrylate, a (meth)acrylamide monomer, or an N-vinyl lactam, and the water absorption percentage of the intraocular lens material is 1.5 to 4.5% by mass (see, for example, PTL 1). This intraocular lens material is excellent in flexibility and has a high refractive index. Therefore, a lens with a reduced thickness can be provided, and the lens in a folded state can be inserted through an incision. Moreover, the intraocular lens material has excellent transparency and can reduce the occurrence of glistening.
- PTL 1: Japanese Unexamined Patent Application Publication No. 11-56998
- In an acrylic elastomer using the intraocular lens material in PTL 1, ester moieties may undergo hydrolysis, and dissolution of a hydrolysate may occur although the amount of dissolution is very small. There is therefore a need for a material that can provide an intraocular lens from which only a reduced amount of a hydrolysate dissolves.
- The present invention has been made in view of the foregoing circumstances, and it is a primary object to provide an intraocular lens material from which only a reduced amount of the hydrolysate dissolves in an aqueous solution.
- To achieve the above object, the present inventors have conducted extensive studies and found that, when an intraocular lens material containing an acrylate as a base material contains a specific methacrylate, the amount of a hydrolysate dissolved in an aqueous solution can be further reduced while the desired properties of the intraocular lens material are maintained or improved. Thus, the present invention has been completed.
- Accordingly, an intraocular lens material disclosed in the present description comprises: an aromatic ring-containing acrylate structural unit; an alkoxyalkyl methacrylate structural unit including an alkoxyalkyl group having 4 or less carbon atoms; a hydrophilic structural unit based on a hydrophilic monomer; and a cross-linking structural unit based on a cross-linkable monomer.
- With this intraocular lens material, the amount of a hydrolysate dissolved from the intraocular lens material in an aqueous solution can be further reduced. The reason that this effect is obtained may be, for example, as follows. For example, methacrylate is a material harder than acrylate because of the presence of a methyl group but may resist attack by water. Therefore, hydrolysis resistance may be improved. In the case that the alkoxyalkyl group having 4 or less carbon atoms is included, the number of carbon atoms is preferable, and therefore the intraocular lens material may not be excessively hard and may have sufficient flexibility. Moreover, the intraocular lens material containing the alkoxyalkyl group having 4 or less carbon atoms may be preferred in terms of flexibility, reduction in stickiness, and the ability to reduce the occurrence of glistening. The alkoxyalkyl group may be represented by, for example, chemical formula (1).
-
CnH2n+1OCmH2m— ((n+m)≤4) (1) -
FIG. 1 is a side view of anindenter 10 and ajig 11 that are used for compressive load measurement. -
FIG. 2 is an illustration of a specimen used for elongation percentage measurement. - An intraocular lens material disclosed in an embodiment comprises: an aromatic ring-containing acrylate structural unit; an alkoxyalkyl methacrylate structural unit including an alkoxyalkyl group having 4 or less carbon atoms; a hydrophilic structural unit based on a hydrophilic monomer; and a cross-linking structural unit based on a cross-linkable monomer. This intraocular lens material contains, as a base material, the aromatic ring-containing acrylate structural unit and the alkoxyalkyl methacrylate structural unit including the alkoxyalkyl group having 4 or less carbon atoms. The intraocular lens material may further contain, as a base material, an alkyl acrylate structural unit including an alkyl group having 1 to 20 carbon atoms. The base material is component forming the main structure of the intraocular lens material. As shown in chemical formula (2), the intraocular lens material may contain, as a base material, aromatic ring-containing acrylate structural units A, alkoxyalkyl methacrylate structural units B, and alkyl acrylate structural units C. In chemical formula (2), a, b, and c are any integers. The aromatic ring-containing acrylate structural units A, the alkoxyalkyl methacrylate structural units B, and the alkyl acrylate structural units C are bonded to a carbon chain in an arbitrary manner, and adjacent structural units may be the same or different. A functional group R1 is an aromatic ring-containing functional group, and a functional group R2 is an alkoxyalkyl group including an alkoxy group and having 4 or less carbon atoms. A functional group R3 is an alkyl group having 1 to 20 carbon atoms. As used herein, acrylate having an acryloyl group and methacrylate having a methacryloyl group are collectively referred to as “(meth)acrylate.” For the sake of convenience of description, a structural unit included in a polymer is designated by the name of a corresponding monomer. Monomers exemplified in the description of a polymer structure have structures in which their polymerizable groups are bonded to other structural units. For example, a monomer exemplified as “(meth)acrylate” in the description of a polymer structure is present as a “(meth)acrylate structural unit” in the polymer. In this structural unit, another structural unit is bonded (polymerized) to a double bond of the (meth) acrylate.
- In this intraocular lens material, the aromatic ring-containing acrylate structural unit is a structural unit based on an aromatic ring-containing acrylate used as a base material monomer. This aromatic ring-containing acrylate may be a component having the function of increasing the refractive index of the intraocular lens material. This aromatic ring-containing acrylate structural unit may have a phenoxy group, an alkylene group having 2 or less carbon atoms, and an acrylate bond moiety. Examples of the aromatic ring-containing acrylate include phenoxyethyl acrylate, phenylethyl acrylate, benzyl acrylate, phenyl acrylate, and pentabromophenyl acrylate. These may be used alone, or a mixture of two or more may be used. Of these, at least one of phenoxyethyl acrylate, phenylethyl acrylate, and benzyl acrylate is preferred because their effect of increasing the refractive index is high. Phenoxyethyl acrylate is particularly preferred because it can further enhance flexibility. Preferably, the amount of the aromatic ring-containing acrylate is within the range of from 15 parts by mass to 80 parts by mass inclusive based on 100 parts by mass of the total amount of the base material. More preferably, the amount of the aromatic ring-containing acrylate is from 30 parts by mass to 80 parts by mass inclusive based on 100 parts of the base material because it is desirable that the intraocular lens material has a high refractive index even in a moistened state.
- In the intraocular lens material, the alkoxyalkyl methacrylate structural unit including the alkoxyalkyl group having 4 or less carbon atoms is a structural unit based on an alkoxyalkyl methacrylate used as a base material monomer. The alkoxyalkyl group in the alkoxyalkyl methacrylate may be, for example, a group represented by chemical formula (1) above. Examples of the alkoxy group include a methoxy group and an ethoxy group. Examples of the alkylene group to which the alkoxy group is bonded include a methylene group and an ethylene group. The alkoxyalkyl methacrylate is preferably at least one of methoxyethyl methacrylate and ethoxyethyl methacrylate and more preferably ethoxyethyl methacrylate. The amount of the alkoxyalkyl methacrylate is preferably within the range of from 10 parts by mass to 70 parts by mass inclusive based on 100 parts by mass of the total amount of the base material. From the viewpoint that the degree of hydrolysis can be further reduced and from the viewpoint of ease of folding, the amount of the alkoxyalkyl methacrylate is more preferably from 20 parts by mass to 40 parts by mass inclusive based on 100 parts by mass of the base material. An example of the structure of the intraocular lens material is shown in chemical formula (3). In this example, the base material is 2-phenoxyethyl acrylate (POEA), ethyl acrylate (EA), and ethoxyethyl methacrylate (ETMA). In chemical formula (3), a, b, and c are any integers. The aromatic ring-containing acrylate structural units A, the alkoxyalkyl methacrylate structural units B, and the alkyl acrylate structural units C are bonded to a carbon chain in an arbitrary manner, and adjacent structural units may be the same or different.
- In the intraocular lens material, the alkyl acrylate structural unit including the alkyl group having 1 to 20 carbon atoms is a structural unit based on an alkyl acrylate used as a base material monomer. The alkyl acrylate including the alkyl group having 1 to 20 carbon atoms may be a component having the function of improving the shape recoverability and flexibility of the intraocular lens material. Examples of the alkyl acrylate include straight-chain, branched-chain, and cyclic alkyl acrylates such as methyl acrylate, ethyl acrylate, propyl acrylate, butyl acrylate, pentyl acrylate, hexyl acrylate, heptyl acrylate, nonyl acrylate, stearyl acrylate, octyl acrylate, decyl acrylate, lauryl acrylate, pentadecyl acrylate, 2-ethylhexyl acrylate, cyclopentyl acrylate, and cyclohexyl acrylate. Other examples of the alkyl acrylate include fluorine-containing alkyl (meth)acrylates such as 2,2,2-trifluoroethyl acrylate, 2,2,3,3-tetrafluoropropyl acrylate, 2,2,3,3-tetrafluoro-t-pentyl acrylate, 2,2,3,4,4,4-hexafluorobutyl acrylate, 2,2,3,4,4,4-hexafluoro-t-hexyl acrylate, 2,3,4,5,5,5-hexafluoro-2,4-bis(trifluoromethyl)pentyl acrylate, 2,2,3,3,4,4-hexafluorobutyl acrylate, 2,2,2,2′,2′,2′-hexafluoroisopropyl acrylate, 2,2,3,3,4,4,4-heptafluorobutyl acrylate, and 2,2,3,3,4,4,5,5-octafluoropentyl acrylate. These may be used alone, or a mixture of two or more may be used. Of these, alkyl acrylates including an alkyl group having 1 to 5 carbon atoms are preferred because their effect of improving the shape recoverability and flexibility is high, and ethyl acrylate and butyl acrylate are particularly preferably used. Preferably, the amount of the alkyl acrylate is within the range of from 0 parts by mass to 35 parts by mass inclusive based on 100 parts by mass of the total amount of the base material. The alkyl acrylate is regarded as one of the base material but is not necessarily an essential component. In terms of the flexibility and shape recoverability, the amount of the alkyl acrylate may be appropriately adjusted at the above ratio.
- In the intraocular lens material, the hydrophilic structural unit is a structural unit based on a hydrophilic monomer. The hydrophilic monomer is a component that provides hydrophilicity to the intraocular lens material and may be a component having the function of facilitating a reduction in the occurrence of glistening in the intraocular lens material. The hydrophilic monomer may include, for example, at least one of hydroxyl group-containing alkyl (meth)acrylates including an alkyl group having 1 to 20 carbon atoms, (meth)acrylamide monomers, and N-vinyl lactams. An additional hydrophilic monomer other than the above hydrophilic monomers may be included. Examples of the hydroxyl group-containing alkyl (meth)acrylate include: hydroxyalkyl (meth)acrylates such as hydroxyethyl (meth) acrylate, hydroxypropyl (meth) acrylate, hydroxybutyl (meth)acrylate, and hydroxypentyl (meth)acrylate; and dihydroxyalkyl (meth)acrylates such as dihydroxypropyl (meth)acrylate, dihydroxybutyl (meth)acrylate, and dihydroxypentyl (meth)acrylate. Examples of the (meth)acrylamide monomer include N,N-dialkyl(meth)acrylamides such as N,N-dimethyl(meth)acrylamide, N,N-diethyl(meth)acrylamide, and N,N-dipropyl(meth)acrylamide; and N,N-dialkylaminoalkyl(meth)acrylamides such as N,N-dimethylaminopropyl(meth)acrylamide and N,N-diethylaminopropyl(meth)acrylamide. Examples of the N-vinyl lactam include N-vinylpyrrolidone, N-vinylpiperidone, and N-vinylcaprolactam. Examples of the additional hydrophilic monomer include diethylene glycol mono(meth)acrylate, triethylene glycol mono(meth)acrylate, propylene glycol mono(meth)acrylate, (meth)acrylic acid, 1-methyl-3-methylene-2-pyrrolidinone, maleic anhydride, maleic acid, maleic acid derivatives, fumaric acid, fumaric acid derivatives, aminostyrene, and hydroxystyrene. The above-described hydrophilic monomers may be used alone, or a mixture of two or more may be used. Among these hydrophilic monomers, hydroxyl group-containing alkyl (meth)acrylates and (meth)acrylamide monomers are preferred because their function of facilitating a reduction in the occurrence of glistening is high, and 2-hydroxyethyl methacrylate is particularly preferred. Preferably, the content of the hydrophilic monomer is within the range of from 15 parts by mass to 35 parts by mass inclusive by the outside ratio based on 100 parts by mass of the total amount of the base material. When the content of the hydrophilic monomer is within this range, the effect of facilitating a reduction in the occurrence of glistening can be sufficiently obtained, and no significant burden and difficulty arise when the intraocular lens material in a dry state is folded.
- In the intraocular lens material, the cross-linking structural unit is a structural unit based on a cross-linkable monomer. The cross-linkable monomer may be a component that has the function of controlling the flexibility of the intraocular lens material, the function of imparting good mechanical properties, the function of further improving the shape recoverability, and the function of improving copolymerizability of the polymerizable components such as the hydrophilic monomer and other polymerizable monomers. Examples of the cross-linkable monomer include butanediol di(meth)acrylate, ethylene glycol di(meth)acrylate, diethylene glycol di(meth)acrylate, triethylene glycol di(meth)acrylate, propylene glycol di(meth)acrylate, dipropylene glycol di(meth)acrylate, diallyl fumarate, allyl (meth)acrylate, vinyl (meth)acrylate, trimethylolpropane tri(meth)acrylate, methacryloyloxyethyl (meth)acrylate, divinylbenzene, diallyl phthalate, diallyl adipate, triallyl diisocyanate, α-methylene-N-vinylpyrrolidone, 4-vinylbenzyl (meth)acrylate, 3-vinylbenzyl (meth)acrylate, 2,2-bis((meth)acryloyloxyphenyl)hexafluoropropane, 2,2-bis((meth)acryloyloxyphenyl)propane, 1,4-bis(2-(meth)acryloyloxyhexafluoroisopropyl)benzene, 1,3-bis(2-(meth)acryloyloxyhexafluoroisopropyl)benzene, 1,2-bis(2-(meth)acryloyloxyhexafluoroisopropyl)benzene, 1,4-bis(2-(meth)acryloyloxyisopropyl)benzene, 1,3-bis(2-(meth)acryloyloxyisopropyl)benzene, and 1,2-bis(2-(meth)acryloyloxyisopropyl)benzene. These may be used alone, or a mixture of two or more may be used. Among these cross-linkable monomers, at least one of butanediol di(meth)acrylate and ethylene glycol di(meth)acrylate is particularly preferred because the effect of controlling the flexibility, the effect of imparting good mechanical properties, and the effect of improving the shape recoverability and copolymerizability are high. Preferably, the content of the cross-linkable monomer is within the range of from 2 parts by mass to 4 parts by mass inclusive by the outside ratio based on 100 parts by mass of the total amount of the base material. The content is preferably 2 parts by mass or more from the viewpoint of imparting the shape recoverability and reducing the occurrence of glistening. The content is preferably 4 parts by mass or less because the intraocular lens material can have an elongation percentage high enough to allow insertion from a small incision.
- The intraocular lens material may contain other additional components such as an ultraviolet absorber and a coloring agent. Examples of the ultraviolet absorber include: benzophenones such as 2-hydroxy-4-methoxybenzophenone and 2-hydroxy-4-octoxybenzophenone; benzotriazoles such as 2-(2′-hydroxy-5′-methacryloxyethyleneoxy-t-butylphenyl)-5-methyl-benzotriazole, 2-(2′-hydroxy-5′-methylphenyl)benzotriazole, and 5-chloro-2(3′-t-butyl-2′-hydroxy-5′-methylphenyl)benzotriazole; salicylic acid derivatives; and hydroxyacetophenone derivatives. Preferably, the amount of the ultraviolet absorber added is, for example, within the range of from 0.05 parts by mass to 3 parts by mass inclusive by the outside ratio based on 100 parts by mass of the total amount of the base material. For example, to correct cyanopsia, it is preferable to use a yellow or orange coloring agent. Examples of the coloring agent include: a dye described in Japanese Unexamined Patent Application Publication No. 2006-291006; oil-soluble dyes such as CI Solvent Yellow and CI Solvent Orange listed in the Color Index International (CI); disperse dyes such as CI Disperse Yellow and CI Disperse Orange listed in the Color Index International (CI); and vat dyes. Preferably, the amount of the coloring agent added is within the range of from 0.01 parts by mass to 3 parts by mass inclusive by the outside ratio based on 100 parts by mass of the total amount of the base material.
- For example, a radical polymerization initiator or a photopolymerization initiator may be added for polymerization to obtain the intraocular lens material. For example, a polymerization method in which a radical polymerization initiator is added followed by heating or irradiation with electromagnetic waves such as microwaves, ultraviolet radiation, or radiation (γ radiation) may be used. Examples of the radical polymerization initiator include azobisisobutyronitrile, azobisdimethylvaleronitrile, benzoyl peroxide, t-butyl hydroperoxide, and cumene hydroperoxide. When a light beam, for example, is used for polymerization, it is preferable to further add a photopolymerization initiator or a sensitizer. Examples of the photopolymerization initiator include: benzoin-based compounds such as methyl orthobenzoyl benzoate; phenone-based compounds such as 2-hydroxy-2-methyl-1-phenylpropane-1-one; thioxanthone-based compounds such as 1-hydroxycyclohexyl phenyl ketone, 1-phenyl-1,2-propanedione-2-(o-ethoxycarbonyl)oxime, and 2-chlorothioxanthone; dibenzosuberone; 2-ethylanthraquinone; benzophenone acrylate; benzophenone; and benzil. To allow the polymerization reaction to proceed at a sufficient rate, the amount of the polymerization initiator or sensitizer used is preferably within the range of from 0.01 parts by mass to 2 parts by mass inclusive by the outside ratio based on 100 parts by mass of the total amount of the base material. The intraocular lens material of the present invention may be formed into an intraocular lens using, for example, lathing or molding.
- In the intraocular lens material, glistening is less likely to occur. When the material in the form of a lens is evaluated using an experimental method described in the present description, the number of glistening spots per a lens is preferably 15 or less. When the material in the form of a plate is evaluated using the above method, the number of glistening spots per a plate is preferably 6 or less and more preferably 2 or less.
- The intraocular lens material has an elongation percentage high enough to allow insertion from a small incision. Specifically, when the material is evaluated using an experimental method described in the present description, the elongation percentage is preferably 170% or more. In terms of the shape recoverability of the intraocular lens material, the elongation percentage is preferably 600% or less.
- In the intraocular lens material, the dissolution rate of phenoxyethyl alcohol (POEtOH), which is a hydrolysate of the material, after the material has been stored in water at 100° C. for 30 days is preferably 0.13% by mass or less and more preferably 0.10% by mass or less. In the intraocular lens material, the dissolution rate of POEtOH from the material after the material has been stored in water at 100° C. for 60 days is preferably 0.80% by mass or less and more preferably 0.70% by mass or less. In the intraocular lens material, the dissolution rate of POEtOH from the material after the material has been stored in water at 100° C. for 90 days is preferably 3.30% by mass or less and more preferably 2.80% by mass or less. The smaller the dissolution rate, the more preferred.
- In the intraocular lens material, the water absorption percentage (% by mass) of the material is preferably within the range of from 1.5% by mass to 4.5% by mass inclusive. When the water absorption percentage is 1.5% by mass or more, the occurrence of glistening can be reduced. When the water absorption percentage is 4.5% by mass or less, a reduction in flexibility and a reduction in shape recoverability can be suppressed. As described above, the intraocular lens material of the present invention is excellent in flexibility and has a high refractive index. Therefore, a lens with a reduced thickness can be provided, and the lens in a folded state can be inserted through a small incision. Moreover, the intraocular lens material has excellent transparency and can reduce the occurrence of glistening.
- With the intraocular lens material in the present embodiment described above in detail, the amount of the hydrolysate dissolved from the intraocular lens material in an aqueous solution can be reduced. The reason that the above effect is obtained is that, for example, the alkoxyalkyl methacrylate including the alkoxyalkyl group having 4 or less carbon atoms is included in addition to the acrylates used as a base material. Generally, methacrylate is a material harder than acrylate because of the presence of a methyl group but resists attack by water, and therefore hydrolysis resistance may be improved. When the number of methacrylate structural units is increased, glistening often occurs easily. Although this mechanism is not clear, since the polymerization rate of acrylic differs from the polymerization rate of methacrylic, phase separation easily occurs, so that glistening seems to occur easily. However, in the intraocular lens material in the present embodiment, the alkoxyalkyl methacrylate is used as methacrylate, so that the ability to reduce the occurrence of glistening does not seem to be lost. Moreover, the alkoxyalkyl methacrylate having 4 or less carbon atoms is preferred in terms of flexibility, reduction in stickiness, and the ability to reduce the occurrence of glistening.
- The present invention is not limited to the above-described embodiment. It will be appreciated that the invention can be embodied in various forms so long as they fall within the technical scope of the invention.
- Examples in which the intraocular lens of the present invention was actually produced will be described as Experimental Examples. Experimental Examples 7 to 14, 18, 20, 21, 23, 24, 26 to 29, 31, 32, 34, 35, 37 to 43, 45 to 53, 55, 57, 59, and 60 correspond to Examples of the present invention. Experimental Examples 1 to 6, 15 to 17, 19, 22, 25, 30, 33, 36, 44, 54, 56, and 58 correspond to Comparative Examples. The present invention is not limited to the following Examples, and it will be appreciated that the invention can be embodied in various forms so long as they fall within the technical scope of the invention.
- [Components Used]
- Abbreviations for the compounds used in the Experimental Examples are shown below.
-
- POEA: 2-phenoxyethyl acrylate
- EA: ethyl acrylate
- POEMA: phenoxyethyl methacrylate
- EMA: ethyl methacrylate
- BMA: butyl methacrylate
- EHMA: ethylhexyl methacrylate
- LMA: lauryl methacrylate
- MTMA: methoxyethyl methacrylate
- ETMA: ethoxyethyl methacrylate
-
- HEMA: 2-hydroxyethyl methacrylate
-
- BDDA: 1,4-butanediol diacrylate
- [Preparation of Plate-Shaped and Lens-Shaped Intraocular Lens Materials]
- Polymerizable components shown in Table 1 were mixed with 0.5 parts by mass of 2,2′-azobis(2,4-dimethylvaleronitrile) as a polymerization initiator by the outside ratio based on 100 parts by mass of the total amount of the base material. The mixture was poured into a mold having a desired lens shape. The mold was placed in an oven at 80° C., and the mixture was subjected to heat polymerization molding for 40 minutes. The polymer obtained was removed from the mold and subjected to elution treatment. Then the resulting polymer was dried in an oven at 60° C., and a lens-shaped intraocular lens material (one of Experimental Examples 1 to 14) was thereby obtained. Similarly, polymerizable components shown in Tables 2 to 4 were used and poured into a mold having a desired plate shape, and the same procedure as described above was repeated to obtain a plate-shaped intraocular lens material (one of Experimental Examples 15 to 60). Plate specimens with the same number (composition) but two different thicknesses were prepared according to the required measurement items. A plate with a thickness of 0.5 mm or 0.8 mm described later is a plate prepared using a mold with a 0.5 mm or 0.8 mm-thick spacer. Each dried plate was punched into a measurement plate with a diameter of 6 mm or 8 mm according to a test purpose.
-
TABLE 1 Hydrophilic Base material monomer Cross-linkable POEA EA POEMA EHMA LMA ETMA HEMA monomer Specimen Parts Parts Parts Parts Parts Parts Parts by BDDA (Lens) by mass by mass by mass by mass by mass by mass mass Parts by mass Experimental 40 20 40 15 4 example 1 Experimental 60 40 15 4 example 2 Experimental 60 20 20 15 4 example 3 Experimental 60 20 20 15 4 example 4 Experimental 30 40 30 15 4 example 5 Experimental 70 30 15 3 example 6 Experimental 60 40 15 2 example 7 Experimental 60 20 20 15 2 example 8 Experimental 60 20 20 15 2.5 example 9 Experimental 60 20 20 15 3 example 10 Experimental 60 15 25 15 2.5 example 11 Experimental 60 15 25 15 3 example 12 Experimental 60 10 30 15 2.5 example 13 Experimental 60 10 30 15 3 example 14 -
TABLE 2 Hydrophilic Cross-linkable Base material monomer monomer POEA EA EMA BMA LMA MTMA ETMA HEMA BDDA Specimen Parts Parts Parts Parts Parts Parts Parts Parts by Parts by (Plate) by mass by mass by mass by mass by mass by mass by mass mass mass Experimental 60 40 15 4 example 15 Experimental 60 40 15 4 example 16 Experimental 60 20 20 15 4 example 17 Experimental 60 40 15 4 example 18 Experimental 60 40 15 4 example 19 Experimental 60 20 20 15 4 example 20 Experimental 60 40 15 4 example 21 -
TABLE 3 Hydrophilic Base material monomer Cross-linkable POEA EA ETMA HEMA monomer Specimen Parts Parts Parts Parts by BDDA (Plate) by mass by mass by mass mass Parts by mass Experimental 60 40 15 3 example 22 Experimental 60 20 20 15 3 example 23 Experimental 60 40 15 3 example 24 Experimental 60 40 15 2 example 25 Experimental 60 30 10 15 2 example 26 Experimental 60 20 20 15 2 example 27 Experimental 60 15 25 15 2 example 28 Experimental 60 40 15 2 example 29 Experimental 60 40 20 4 example 30 Experimental 60 20 20 20 4 example 31 Experimental 60 40 20 4 example 32 Experimental 60 40 20 3 example 33 Experimental 60 20 20 20 3 example 34 Experimental 60 40 20 3 example 35 Experimental 60 40 20 2 example 36 Experimental 60 20 20 20 2 example 37 Experimental 60 40 20 2 example 38 -
TABLE 4 Hydrophilic Base material monomer Cross-linkable POEA EA ETMA HEMA monomer Specimen Parts Parts Parts Parts by BDDA (Plate) by mass by mass by mass mass Parts by mass Experimental 60 20 20 25 4 example 39 Experimental 60 40 25 4 example 40 Experimental 50 50 25 4 example 41 Experimental 40 60 25 4 example 42 Experimental 30 70 25 4 example 43 Experimental 20 80 25 4 example 44 Experimental 60 20 20 25 3 example 45 Experimental 60 40 25 3 example 46 Experimental 60 20 20 25 2 example 47 Experimental 60 40 25 2 example 48 Experimental 60 40 35 4 example 49 Experimental 50 50 35 4 example 50 Experimental 40 60 35 4 example 51 Experimental 60 40 40 4 example 52 Experimental 60 40 45 4 example 53 Experimental 60 40 60 4 example 54 Experimental 60 30 10 20 3 example 55 Experimental 60 40 25 3 example 56 Experimental 60 30 10 25 3 example 57 Experimental 60 40 25 2 example 58 Experimental 60 30 10 25 2 example 59 Experimental 60 10 30 25 2 example 60 - <Measurement of Physical Properties>
- A specimen was dried at 60° C. in advance, and its pre-treatment mass W0 was measured. 50 mL of distilled water was placed in a 100 mL pressure bottle, and the specimen was immersed therein. The pressure bottle was placed in an incubator at 100° C. and stored therein. Ten plates with a diameter of 6 mm and a thickness of 0.5 mm were used as the specimen. The tare mass W01 of the bottle, the mass W02 of the bottle after the addition of distilled water, and the mass W03 of the bottle after the immersion of the specimen were recorded.
- (Dissolution Rate of POEtOH)
- The concentration of phenoxyethyl alcohol (POEtOH, hydrolysate of POEA) in the extraction solution and the dissolution rate of POEtOH after 30 days of the hydrolysis treatment were determined using the following procedure. The mass W11 of the bottle before collection of the extraction solution was recorded. Then the extraction solution was collected from the bottle, and the mass W12 of the bottle after the collection of the extraction solution was recorded. The collected extraction solution, standard solutions, and a blank (distilled water) were analyzed using HPLC. After the analysis, the chromatogram of the distilled water was subtracted from the chromatograms of the collected extraction solution and the standard solutions to perform baseline correction. The area of the peak of POEtOH in each of the corrected chromatograms was calculated. A calibration curve was produced from the POEtOH concentrations and peak areas of the standard solutions. The concentration of POEtOH in the extraction solution was calculated using the area of the peak of POEtOH in the extraction solution and the calibration curve obtained. The dissolution rate of POEtOH per 1 g of the specimen was calculated from formula (1) below using the POEtOH concentration obtained. The volume of the extraction solution was calculated from formula (2). The volume of the extraction solution was calculated based on the following premises. The change in the mass of the specimen during heating at 100° C. is negligibly smaller than the change in the mass of the extraction solution. Since the most part of the extraction solution is water, the computation can be performed using 1 g/mL as the density of the extraction solution without any problem. After the analysis of the extraction solution after 30 days of the hydrolysis treatment, the bottle was again placed in the incubator at 100° C. After a total of 60 days of the hydrolysis treatment, the extraction solution was again collected. The same procedure as that preformed after 30 days of the treatment was repeated. Specifically, the mass W21 of the bottle before collection of the extraction solution was recorded. Then the concentration of POEtOH in the extraction solution was quantified by HPLC analysis, and the dissolution rate of POEtOH was calculated from formula (3). The volume of the extraction solution was calculated from formula (4). Similarly, the dissolution rate of POEtOH after a total of 90 days of the hydrolysis treatment was calculated.
-
The dissolution rate of POEtOH (%)=the concentration of POEtOH in the extraction solution (ppm)×10−6×the volume of the extraction solution V 1S (mL)/pre-treatment mass W 0 (g)×100 Formula (1) -
The volume of the extraction solution V 1S (mL≈g)=[W 02 (g)−W 01 (g)]−[W 03 (g)−W 11 (g)] Formula (2) -
The dissolution rate of POEtOH (%)=the concentration of POEtOH in the extraction solution (ppm)×10−6×the volume of the extraction solution V 2S (mL)/pre-treatment mass W 0 (g)×100 Formula (3) -
The volume of the extraction solution V 2S (mL≈g)=V 1S (mL≈g)−[W 11 (g)−W 12 (g)]−[W 12 (g)−W 21 (g)] Formula (4) - (Glistening)
- In the measurement of glistening, lens-shaped specimens with a diameter of 6 mm and a center thickness of 0.8 mm±0.1 mm or plate specimens with a diameter of 6 mm and a thickness of 0.5 mm were used. The lens-shaped specimens were immersed in water at 35° C. for 17 hours or longer and then immersed in water at 25° C. for 2 hours, and the appearance was observed under a stereoscopic microscope. The plate specimens were immersed in water at 35° C. for 22 hours and then immersed in water at 25° C. for 2 hours, and the appearance was observed under a stereoscopic microscope. In each experimental example, the observation of the appearance was performed on 2 or 3 specimens, and the number of glistening spots (bright spots) formed was examined. The magnification used was about 10× to about 60×. The magnification was appropriately adjusted within the above range so that the glistening was easily observed.
- (Water Absorption Percentage)
- The mass of each specimen in an equilibrium moisture state and its mass in a dry state were measured, and the water absorption percentage (mass %) of the specimen was calculated. The water absorption percentage was calculated from formula (5) below using the mass Ww of the specimen in the equilibrium moisture state at 25° C. and the mass Wd of the specimen in the dry state. Five plates with a diameter of 6 mm and a thickness of 0.8 mm were used as the specimens.
-
The water absorption percentage (mass %)=(W w −W d)/W d×100 Formula (5) - (Refractive Index)
- The refractive index of each specimen was determined using the Mercury e-line in an Abbe refractometer. The measurement was performed on the specimen in a dry state (25° C.) or a moisture state (35° C.). The specimen used was a plate with a diameter of 6 mm and a thickness of 0.8 mm.
- (Compressive Load (Plate))
- A plate with a diameter of 6 mm and a thickness of 0.5 mm was compressed and buckled (bending buckling) according to the following procedure. Then a load value when the specimen was buckled from 6 mm to 3 mm was measured as a compressive load value. Before the measurement, the specimen was left to stand in an environment at 23° C. and 50% RH to control its state.
FIG. 1 is a side view of anindenter 10 and ajig 11 used for the measurement of the compressive load. Each of theindenter 10 and thejig 11 is made of polyoxymethylene (DURACON) and has a cylindrical shape. Theindenter 10 and thejig 11 were attached to a creep meter (RE2-33005S manufactured by Yamaden Co., Ltd.). A double-sided adhesive tape (3M Scotch Brand Tape core series 2-0300) was attached to a specimen placement area on the upper surface of thejig 11, and thespecimen 12 was placed. A specimen stage (support) with thejig 11 attached thereto was moved up and down to bring thespecimen 12 into contact with theindenter 10. The specimen stage was moved up 3.2 mm from the contact position at a compression speed of 0.5 mm/sec to buckle the specimen. A load when the specimen stage was moved up 3 mm was used as the compressive load value. - (Stickiness)
- In the measurement of stickiness, a plate with a diameter of 8 mm and a thickness of 0.8 mm was used. A jig for the stickiness measurement was attached to a specimen stage (support) of a creep meter. A part of the jig was detached, and the specimen was fitted into a part of the detached jig. Then the jig integrated with the specimen was attached to the creep meter. The specimen stage was moved to bring the specimen into contact with a metallic probe (radius of curvature: 2.5 mm) such that a force of 0.05 N was applied to the specimen, and the stage was stopped at this position. About 5 seconds after the stage had been stopped, the specimen was separated from the probe at a separation speed of 1 mm/sec, and a load applied to the specimen was measured using the creep meter (RE2-33005S manufactured by Yamaden Co., Ltd.). A value of stickiness was calculated by subtracting the load after the probe had been separated from the specimen (the load after separation) from the maximum load measured. When the stickiness value was 0 N or more and less than 0.16 N, the specimen was rated “A”. When the stickiness value was 0.16 N or more and less than 0.30 N, the specimen was rated “B”. When the stickiness value was 0.30 N or more, the specimen was rated “C”.
- (Tensile Test)
- Measurement was performed using a dumbbell-shaped specimen with a total length (L0) of 20 mm, a parallel-portion length (L) of 6 mm, a parallel-portion width (W) of 1.5 mm, and a thickness of 0.8 mm (see
FIG. 2 ). The specimen was immersed in water held at a constant temperature of 25° C., left to stand for 1 minute, and then pulled at a speed of 100 mm/min until break. The strain at the maximum load (=elongation percentage (%)) was determined using software. - (Results and Discussion)
- The results for lens-shaped Experimental Examples 1 to 14 are shown in Table 5, and the results for plate-shaped Experimental Examples 15 to 60 are shown in Tables 6 to 9. As can be seen from the results in Tables 6 to 9, the degree of hydrolysis can be reduced by increasing the number of methacrylate structural units, and alkoxymethacrylates are suitable for the methacrylate component. In the compositions of Experimental Examples 1 to 6 in Table 5, the amounts of acrylates (POEA and EA) used as a base material are less than those in the composition described in PTL 1, and POEMA, EHMA, or LMA is added. In the materials of Experimental Examples 1 to 3 to which LMA was added, the stickiness was high. Moreover, the materials were brittle and easily broken, and glistening occurred easily. In the material of Experimental Example 4 to which EHMA was added, glistening occurred easily. In the materials of Experimental Examples 5 and 6 to which POEMA was added, glistening occurred easily, and these materials were hard. However, in the materials of Experimental Examples 7 to 14 to which ETMA, which is an alkoxymethacrylate, was added, the stickiness was low. Moreover, these materials were not brittle.
- In the compositions of Experimental Examples 15 to 17 in Table 6, the amounts of acrylates (POEA and EA) used as a base material are less than those in the composition described in PTL 1, and EMA, BMA, or LMA is added. In the material of Experimental Example 15 to which EMA was added, the amount of dissolution of POEtOH was small, and it seemed that the degree of hydrolysis was reduced, but it was obvious that the intraocular lens material was not easily folded. In the material of Experimental Example 16 to which BMA was added, the amount of dissolution of POEtOH was small, and it seemed that the degree of hydrolysis was reduced, but glistening occurred easily. In the material of Experimental Example 17 to which LMA was added, stickiness was high. Moreover, the material was brittle and easily broken, and glistening occurred easily. In the materials of Experimental Examples to which one of MTMA or ETMA, which are alkoxymethacrylates, was added, the amount of dissolution of POEtOH was small, and the degree of hydrolysis was reduced. Moreover, the stickiness was not high. As in 6, the occurrence of glistening was low, and the materials were not brittle.
- As can be seen from the results in Tables 5 to 9, a suitable amount of the alkoxymethacrylate added is preferably from 10 parts by mass to 70 parts by mass inclusive and more preferably from 20 parts by mass to 40 parts by mass inclusive based on 100 parts by mass of the base material. The minimum amount of the alkoxymethacrylate is preferably within the above range mainly from the viewpoint of the reduction in the degree of hydrolysis, and the maximum amount of the alkoxymethacrylate is preferably within the above range from the viewpoint of ease of folding and from the viewpoint that no significant burden and difficulty arise during folding.
- The amount of the aromatic ring-containing acrylate used as a base material is preferably 30 parts by mass or more based on 100 parts by mass of the base material from the viewpoint that the intraocular lens material in a hydrated state can have a refractive index of 1.50 or more. As the refractive index of the material increases, a thinner lens can be used to obtain a desired refractive power. The thinner the lens, the more easily the folded lens can be inserted into an eye.
- The amount of the hydrophilic monomer is preferably 15 parts by mass or more by the outside ratio based on 100 parts by mass of the total amount of the base material from the viewpoint of reducing the occurrence of glistening and is preferably 35 parts by mass or less by the outside ratio in order that no significant burden and difficulty arise during folding in a dry state. When the intraocular lens material in the dry state can be easily bent, the intraocular lens material can be stored, distributed and used in an injector device. The compressive load in Table 8 is a value when the compressive load in Experimental Example 54 is set to 1. The material of Experimental Example 54 was evaluated in PTL 1, and the evaluation indicates that this material can be folded, but a large extra force is necessary. When the compressive load value of a material is equal to or larger than that of the material of Experimental Example 54, a determination is made that a significant burden and difficulty may arise during folding. In Experimental Examples 50 to 53 shown in Table 8, since ETMA was contained, the amount of dissolution of POEtOH was small, and the effect of reducing the degree of hydrolysis was obtained. However, since the amount of ETMA or HEMA was large, the foldability was not good.
- The amount of the cross-linkable monomer is preferably 2 parts by mass or more by the outside ratio based on 100 parts by mass of the total amount of the base material from the viewpoint of reducing the occurrence of glistening and from the viewpoint of shape recoverability after insertion into an eye and is preferably 4 parts by mass or less by the outside ratio in order to prevent the elongation of the material to be reduced so that the material does not break easily.
-
TABLE 5 Glistening Specimen Number of the (Lens) spots1) Experimental — example 1 Experimental — example 2 Experimental 19 example 3 Experimental 35 example 4 Experimental — example 5 Experimental ∞ example 6 Experimental 4 example 7 Experimental — example 8 Experimental — example 9 Experimental — example 10 Experimental — example 11 Experimental — example 12 Experimental — example 13 Experimental — example 14 1)Measurement result with lens Average value of number of tests (n = 2 or 3) -
TABLE 6 Dissolution Dissolution Dissolution of of of POEtOH POEtOH POEtOH Refractive index Water (100° C., (100° C., (100° C., Glistening 35° C. Elongation absorption Specimen 30 days) 60 days) 90 days) Number of Stickiness 25° C. Water percentage percentage (Plate) ppm % ppm % ppm % the spots1) —2) Dry absorption % % Experimental 1 0.04 4 0.11 3 0.10 — — — — — — example 15 Experimental 2 0.05 4 0.13 5 0.15 10 — — — — — example 16 Experimental — — — — — — — — — — 139 — example 17 Experimental 3 0.08 8 0.23 15 0.39 2 — — — — — example 18 Experimental 6 0.18 40 1.24 192 5.57 2 B 1.523 1.517 — 1.7 example 19 Experimental 3 0.10 15 0.43 49 1.31 — — 1.525 1.519 — 1.8 example 20 Experimental 2 0.06 7 0.21 15 0.41 0 A 1.527 1.522 — 1.9 example 21 1)Measurement result by a plate with as diameter of 6 mm and a thickness of 0.5 mm. Average value of number of tests (n = 3). 2)A: 0N or more and less than 0.16N, B: 0.16N or more and less than 0.30N, C: 0.30N or more -
TABLE 7 Dissolution Dissolution Dissolution of of of POEtOH POEtOH POEtOH Refractive index Water (100° C., (100° C., (100° C., Glistening 35° C. Elongation absorption Specimen 30 days) 60 days) 90 days) Number of Stickiness 25° C. Water percentage percentage (Plate) ppm % ppm % ppm % the spots1) —2) Dry absorption % % Experimental 6 0.19 43 1.28 205 5.80 — C 1.523 1.517 — 1.6 example 22 Experimental 3 0.11 15 0.48 53 1.56 — — 1.525 1.519 — 1.8 example 23 Experimental 2 0.06 5 0.16 10 0.27 — A 1.527 1.521 — 2.0 example 24 Experimental 6 0.18 43 1.16 209 5.29 — C 1.523 1.518 — 1.6 example 25 Experimental 5 0.13 25 0.67 111 2.76 — — — — — — example 26 Experimental 3 0.09 16 0.40 51 1.24 — — 1.525 1.519 — 1.8 example 27 Experimental 3 0.09 12 0.32 33 0.86 — — — — — — example 28 Experimental 2 0.05 6 0.16 11 0.28 — — 1.527 1.521 345 2.1 example 29 Experimental 5 0.16 36 1.06 162 4.48 — B 1.522 1.516 — 2.1 example 30 Experimental 3 0.10 15 0.41 44 1.17 — B 1.524 1.518 — 2.4 example 31 Experimental 2 0.06 6 0.17 10 0.28 — A 1.527 1.521 — 2.4 example 32 Experimental 5 0.15 33 0.97 150 4.09 — B 1.522 1.516 — 2.3 example 33 Experimental 3 0.09 12 0.37 38 1.06 0 B 1.524 1.518 — 2.2 example 34 Experimental 2 0.06 6 0.18 10 0.29 — A 1.527 1.520 — 2.7 example 35 Experimental 6 0.17 38 1.03 176 4.47 — C 1.522 1.516 — 2.2 example 36 Experimental 3 0.08 13 0.33 41 0.97 1 B 1.524 1.518 — 2.5 example 37 Experimental 2 0.06 6 0.17 12 0.30 — A 1.527 1.520 — 2.8 example 38 1)Measurement result by a plate with as diameter of 6 mm and a thickness of 0.5 mm. Average value of number of tests (n = 3). 2)A: 0N or more and less than 0.16N, B: 0.16N or more and less than 0.30N, C: 0.30N or more -
TABLE 8 Dissolution Dissolution Dissolution of of of POEtOH POEtOH POEtOH Refractive index Water (100° C., (100° C., (100° C., Glistening 35° C. Compressive absorption Specimen 30 days) 60 days) 90 days) Number of Stickiness 25° C. Water load percentage (Plate) ppm % ppm % ppm % the spots1) —2) Dry absorption —3) % Experimental 3 0.09 13 0.36 37 0.95 — A 1.524 1.517 — 3.1 example 39 Experimental 2 0.06 6 0.18 10 0.27 — A 1.526 1.520 — 3.3 example 40 Experimental 2 0.06 5 0.16 7 0.19 — — 1.520 1.512 — — example 41 Experimental 2 0.05 4 0.13 3 0.10 — — 1.514 1.507 — — example 42 Experimental 2 0.06 5 0.13 4 0.10 — — 1.509 1.500 0.7 — example 43 Experimental 1 0.04 3 0.09 1 0.02 — — 1.503 1.495 — — example 44 Experimental 2 0.07 10 0.29 29 0.79 1 A 1.524 1.517 — 3.0 example 45 Experimental 2 0.05 5 0.16 8 0.23 — A 1.526 1.520 — 3.1 example 46 Experimental 3 0.09 13 0.34 36 0.88 — B 1.524 1.517 — 3.0 example 47 Experimental 2 0.06 6 0.17 11 0.29 — A 1.526 1.519 — 3.2 example 48 Experimental 2 0.06 6 0.19 10 0.28 — — — — 0.8 — example 49 Experimental 2 0.06 5 0.15 6 0.17 — — 1.520 1.510 1.1 — example 50 Experimental 2 0.05 4 0.12 4 0.10 — — 1.514 1.504 1.3 — example 51 Experimental 2 0.07 7 0.19 12 0.29 — — — — 1.8 — example 52 Experimental 2 0.06 6 0.18 8 0.23 — — — — 1.6 — example 53 Experimental — — — — — — — — — — 1.0 — example 54 1)Measurement result by a plate with as diameter of 6 mm and a thickness of 0.5 mm. Average value of number of tests (n = 3). 2)A: 0N or more and less than 0.16N, B: 0.16N or more and less than 0.30N, C: 0.30N or more 3)Each value of experimental examples is standardized by determining the compressive load of experimental example 54 as “1”. -
TABLE 9 Dissolution of Dissolution of Dissolution of POEtOH POEtOH POEtOH (100° C., (100° C., (100° C., Specimen 30 days) 60 days) 90 days) (Plate) ppm % ppm % ppm % Experimental 5 0.14 24 0.66 91 2.33 example 55 Experimental 5 0.15 31 0.83 134 3.33 example 56 Experimental 5 0.13 23 0.61 79 1.92 example 57 Experimental 4 0.14 28 0.82 119 3.31 example 58 Experimental 5 0.13 23 0.60 79 1.96 example 59 Experimental 3 0.09 11 0.30 25 0.63 example 60 - The present application claims priority from Japanese Patent Application No. 2016-148426 filed on Jul. 28, 2016, the entire contents of which are incorporated herein by reference.
- The invention disclosed in the present description can be used for intraocular lens applications.
- 10 indenter,
- 11 jig,
- 12 specimen.
Claims (11)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016-148426 | 2016-07-28 | ||
JP2016148426 | 2016-07-28 | ||
PCT/JP2017/027176 WO2018021455A1 (en) | 2016-07-28 | 2017-07-27 | Material for intraocular lenses |
Publications (2)
Publication Number | Publication Date |
---|---|
US10117965B1 US10117965B1 (en) | 2018-11-06 |
US20180318464A1 true US20180318464A1 (en) | 2018-11-08 |
Family
ID=61016952
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/772,273 Active US10117965B1 (en) | 2016-07-28 | 2017-07-27 | Intraocular lens material |
Country Status (22)
Country | Link |
---|---|
US (1) | US10117965B1 (en) |
EP (1) | EP3461506B1 (en) |
JP (1) | JP6315646B1 (en) |
KR (2) | KR102075327B1 (en) |
CN (1) | CN108367096B (en) |
AU (1) | AU2017303210B2 (en) |
BR (1) | BR112018077175B1 (en) |
CA (1) | CA3031618C (en) |
DK (1) | DK3461506T3 (en) |
ES (1) | ES2831002T3 (en) |
HK (1) | HK1257888A1 (en) |
IL (1) | IL263939B (en) |
MX (1) | MX2019001108A (en) |
MY (1) | MY190775A (en) |
NZ (1) | NZ749600A (en) |
PH (1) | PH12018502646B1 (en) |
PL (1) | PL3461506T3 (en) |
RU (1) | RU2694208C1 (en) |
SG (1) | SG11201811739YA (en) |
UA (1) | UA119961C2 (en) |
WO (1) | WO2018021455A1 (en) |
ZA (1) | ZA201808052B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3126880A1 (en) * | 2020-09-17 | 2023-03-17 | Acrylian | ACRYLIC COPOLYMER FOR THE MAKING OF INTRAOCULAR LENSES |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6466031B1 (en) * | 2018-01-31 | 2019-02-06 | 株式会社メニコン | Intraocular lens material |
JP7001823B2 (en) * | 2018-01-31 | 2022-02-04 | 株式会社メニコン | Intraocular lens |
WO2020138346A1 (en) | 2018-12-28 | 2020-07-02 | 株式会社ニデック | Soft intraocular lens material and soft intraocular lens |
US11708440B2 (en) | 2019-05-03 | 2023-07-25 | Johnson & Johnson Surgical Vision, Inc. | High refractive index, high Abbe compositions |
US11667742B2 (en) | 2019-05-03 | 2023-06-06 | Johnson & Johnson Surgical Vision, Inc. | Compositions with high refractive index and Abbe number |
CN114096911A (en) | 2019-06-27 | 2022-02-25 | 株式会社目立康 | Ophthalmic medical devices comprising photochromic polymers and methods of making the same |
CN116925281A (en) * | 2019-12-24 | 2023-10-24 | 爱博诺德(北京)医疗科技股份有限公司 | Ophthalmic material and method for producing the same |
KR102387402B1 (en) * | 2020-03-03 | 2022-04-14 | 건양대학교 산학협력단 | Manufacturing method of Hydrophobic Acrylic Intraocular Lens with Reduced Glistening |
JP2023547481A (en) | 2020-10-29 | 2023-11-10 | ジョンソン・アンド・ジョンソン・サージカル・ビジョン・インコーポレイテッド | Compositions with high refractive index and Abbe number |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU696001B2 (en) * | 1995-06-07 | 1998-08-27 | Alcon Laboratories, Inc. | Improved high refractive index ophthalmic lens materials |
JP3641110B2 (en) * | 1997-08-20 | 2005-04-20 | 株式会社メニコン | Materials for soft intraocular lenses |
CA2588951C (en) * | 2004-11-30 | 2013-02-19 | Advanced Medical Optics, Inc. | Biocompatible polymeric compositions for use in making posterior chamber intraocular lenses |
JP4291296B2 (en) | 2005-04-08 | 2009-07-08 | 株式会社メニコン | Novel polymerizable dye and ophthalmic lens containing the same |
US7387642B2 (en) * | 2005-04-13 | 2008-06-17 | Benz Research And Development Corporation | Polymers for intraocular lenses |
TWI426931B (en) * | 2007-10-03 | 2014-02-21 | Alcon Inc | Ophthalmic and otorhinolaryngological device materials |
TWI461186B (en) * | 2007-10-05 | 2014-11-21 | Alcon Inc | Ophthalmic and otorhinolaryngological device materials |
CA2702096A1 (en) * | 2007-10-10 | 2009-04-16 | Benz Research And Development Corp. | Hydrogel with high water content and stability |
WO2009070438A1 (en) * | 2007-11-30 | 2009-06-04 | Bausch & Lomb Incorporated | Optical material and method for modifying the refractive index |
FR2930731B1 (en) * | 2008-04-30 | 2014-06-27 | Acrylian | ACRYLIC POLYMERIC MATERIAL, HYDROPHOBIC FOR INTRAOCULAR LENS |
WO2012004744A2 (en) * | 2010-07-05 | 2012-01-12 | Polymer Technologies International (Eou) | Polymeric composition for ocular devices |
US9144491B2 (en) * | 2011-06-02 | 2015-09-29 | University Of Rochester | Method for modifying the refractive index of an optical material |
TWI551646B (en) * | 2011-06-03 | 2016-10-01 | 諾華公司 | Hydrophobic acrylic intraocular lens materials |
TWI572630B (en) | 2011-09-16 | 2017-03-01 | 班茲研發公司 | Hydrophobic intraocular lens |
FR3013050B1 (en) | 2013-11-13 | 2015-12-11 | O&O Mdc Ltd | METHOD FOR MANUFACTURING HYDROPHOBIC ACRYLIC POLYMER MATERIAL FOR OPHTHALMIC DEVICE |
EP3165544B1 (en) * | 2014-07-04 | 2020-03-18 | Zeon Corporation | Acrylic rubber, acrylic rubber composition, cross-linked acrylic rubber product, and use of cross-linked acrylic rubber product for seal member |
CN105384867B (en) * | 2014-08-20 | 2019-05-24 | 广东东阳光药业有限公司 | A kind of polymer preparing hydrophobicity artificial lens |
-
2017
- 2017-07-27 PL PL17834457T patent/PL3461506T3/en unknown
- 2017-07-27 SG SG11201811739YA patent/SG11201811739YA/en unknown
- 2017-07-27 US US15/772,273 patent/US10117965B1/en active Active
- 2017-07-27 BR BR112018077175-9A patent/BR112018077175B1/en active IP Right Grant
- 2017-07-27 UA UAA201900523A patent/UA119961C2/en unknown
- 2017-07-27 RU RU2019100023A patent/RU2694208C1/en active
- 2017-07-27 DK DK17834457.8T patent/DK3461506T3/en active
- 2017-07-27 JP JP2018505751A patent/JP6315646B1/en active Active
- 2017-07-27 CA CA3031618A patent/CA3031618C/en active Active
- 2017-07-27 AU AU2017303210A patent/AU2017303210B2/en active Active
- 2017-07-27 KR KR1020197024695A patent/KR102075327B1/en active IP Right Grant
- 2017-07-27 NZ NZ749600A patent/NZ749600A/en unknown
- 2017-07-27 ES ES17834457T patent/ES2831002T3/en active Active
- 2017-07-27 MY MYPI2018002446A patent/MY190775A/en unknown
- 2017-07-27 EP EP17834457.8A patent/EP3461506B1/en active Active
- 2017-07-27 CN CN201780004124.9A patent/CN108367096B/en active Active
- 2017-07-27 WO PCT/JP2017/027176 patent/WO2018021455A1/en active Application Filing
- 2017-07-27 KR KR1020197001212A patent/KR20190010713A/en active Search and Examination
- 2017-07-27 MX MX2019001108A patent/MX2019001108A/en unknown
-
2018
- 2018-11-28 ZA ZA2018/08052A patent/ZA201808052B/en unknown
- 2018-12-13 PH PH12018502646A patent/PH12018502646B1/en unknown
- 2018-12-24 IL IL263939A patent/IL263939B/en active IP Right Grant
-
2019
- 2019-01-08 HK HK19100249.8A patent/HK1257888A1/en unknown
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR3126880A1 (en) * | 2020-09-17 | 2023-03-17 | Acrylian | ACRYLIC COPOLYMER FOR THE MAKING OF INTRAOCULAR LENSES |
Also Published As
Publication number | Publication date |
---|---|
KR20190100477A (en) | 2019-08-28 |
ZA201808052B (en) | 2020-05-27 |
BR112018077175B1 (en) | 2020-03-10 |
JP6315646B1 (en) | 2018-04-25 |
CN108367096A (en) | 2018-08-03 |
PH12018502646A1 (en) | 2019-10-14 |
KR20190010713A (en) | 2019-01-30 |
ES2831002T3 (en) | 2021-06-07 |
KR102075327B1 (en) | 2020-02-07 |
AU2017303210B2 (en) | 2019-05-02 |
CA3031618C (en) | 2019-10-22 |
IL263939A (en) | 2019-01-31 |
UA119961C2 (en) | 2019-08-27 |
JPWO2018021455A1 (en) | 2018-07-26 |
CA3031618A1 (en) | 2018-02-01 |
US10117965B1 (en) | 2018-11-06 |
MX2019001108A (en) | 2019-06-10 |
AU2017303210A1 (en) | 2019-01-17 |
PL3461506T3 (en) | 2021-04-06 |
EP3461506B1 (en) | 2020-10-21 |
EP3461506A4 (en) | 2019-07-24 |
PH12018502646B1 (en) | 2019-10-14 |
EP3461506A1 (en) | 2019-04-03 |
SG11201811739YA (en) | 2019-02-27 |
MY190775A (en) | 2022-05-12 |
CN108367096B (en) | 2019-09-27 |
WO2018021455A1 (en) | 2018-02-01 |
BR112018077175A2 (en) | 2019-04-02 |
NZ749600A (en) | 2019-04-26 |
IL263939B (en) | 2019-06-30 |
RU2694208C1 (en) | 2019-07-09 |
HK1257888A1 (en) | 2019-11-01 |
DK3461506T3 (en) | 2020-11-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10117965B1 (en) | Intraocular lens material | |
US10716875B2 (en) | Intraocular lens | |
WO2014062151A1 (en) | High refractive index ophthalmic device materials with reduced tack | |
US8362177B1 (en) | High refractive index ophthalmic device materials with reduced tack | |
EP3251703A1 (en) | Material for intraocular lenses and method for preserving material for intraocular lenses | |
CN111542348B (en) | Material for intraocular lens | |
US9372282B1 (en) | Styrenic ophthalmic and otorhinolaryngological materials and devices formed therewith | |
NZ765293B2 (en) | Intraocular lens |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FEPP | Fee payment procedure |
Free format text: ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: BIG.); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY |
|
AS | Assignment |
Owner name: MENICON CO., LTD., JAPAN Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SUGANUMA, YUYA;NOMURA, HIROKO;OJIO, TATSUYA;SIGNING DATES FROM 20180510 TO 20180514;REEL/FRAME:045804/0523 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 4TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1551); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 4 |